www.insidertrades.com Open in urlscan Pro
104.21.48.1  Public Scan

Submitted URL: https://email.analystratings.net/ls/click?upn=u001.WeKo-2BCuHku2kJmVIsYmGxsYmJ5tlN1JIFNOQtoSEGkJ1H-2B-2B-2BZOzx4KcG2g2dKn1qijBDZ9...
Effective URL: https://www.insidertrades.com/centessa-pharmaceuticals-plc-american-depositary-shares-stock/?AccountID=13091940&hash=%ITHash%&...
Submission: On December 25 via api from BE — Scanned from DE

Form analysis 1 forms found in the DOM

POST ./?AccountID=13091940&hash=%25ITHash%25&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

<form method="post" action="./?AccountID=13091940&amp;hash=%25ITHash%25&amp;utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=newsletterclick" id="form1">
  <div class="aspNetHidden">
    <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKLTY5NjUxMzU2NmRkv0F8Fxjk24IE6ZSv3CkoC2sZuBoCGFx4Q65RQaVLJDU=">
  </div>
  <div class="aspNetHidden">
    <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="FF138D8B">
  </div>
  <div class="page-body">
    <div class="container">
      <h1>CNTA Insider Trading</h1>
      <ul class="horizontal-ul">
        <li>
          <a href="#insider-trading-chart">Insider Trading Chart</a>
        </li>
        <li>
          <a href="#insider-trading-history">Insider Trading History</a>
        </li>
        <li>
          <a href="#insider-trading-faq">Frequently Asked Questions</a>
        </li>
        <li>
          <a href="#about">About</a>
        </li>
      </ul>
      <div class="row d-sm-flex super-border-top super-border-bottom py-1">
        <div class="col"><b>Insider Ownership Percentage:</b> 11.59%</div>
        <div class="col"><b>Insider Buying (Last 12 Months):</b> $0.00</div>
        <div class="col"><b>Insider Selling (Last 12 Months):</b> $11,449,419.49</div>
      </div>
      <div id="insider-trading-chart">
        <h2>Centessa Pharmaceuticals Insider Trading History Chart</h2>
        <p class="sr-only">This chart shows the insider buying and selling history at Centessa Pharmaceuticals by year and by quarter.</p>
        <a href="#price-history" class="sr-only sr-only-focusable">Skip Chart</a><a href="#insider-trading-history" class="sr-only sr-only-focusable">Chart Data in Insider Trading History Table</a>
        <div id="insiderChart" class="dv-chart" style="height:350px;margin-bottom:3em;"></div>
      </div>
      <h2 id="price-history">Centessa Pharmaceuticals Share Price &amp; Price History</h2>
      <div class="row d-sm-flex super-border-top super-border-bottom py-1" style="align-items: baseline; -ms-align-items: baseline;">
        <div class="col h1 m-0" style="position: relative;top: 3px;">
          <span class="sr-only">Current Price: </span><sup>$</sup>16.90
        </div>
        <div class="col" style="flex:1;-ms-flex:1;">
          <div class="c-brown semibold">
            <span class="sr-only">Price Change: </span>▼ <span class="sr-only">Price Decrease of </span>-0.63 (-3.59%)
          </div>
        </div>
        <div class="col" style="padding-bottom: 3px;">As of 12/24/2024 03:33 PM ET</div>
      </div>
      <div class="pt-1">
        <p class="sr-only">This chart shows the closing price history over time for CNTA up to the past year.</p>
        <a href="#sec-filings" class="sr-only sr-only-focusable">Skip Chart and Table Data</a><a href="#insider-trading-history" class="sr-only sr-only-focusable">Price Data in Insider Trading History Table</a>
        <div id="cphPrimaryContent_pnlMiniChart">
          <div class="text-right priceChartOptions"> Days: <span class="draw-price-chart a-green" id="draw30" style="cursor:pointer;">30</span> | <span class="draw-price-chart a-green" id="draw90" style="cursor:pointer;">90</span> | <span
              class="draw-price-chart a-green active" id="draw365" style="cursor:pointer;">365</span>
          </div>
          <div class="mt-1 border">
            <div id="priceChart" class="dv-chart" style="height:333px;">
            </div>
          </div>
        </div>
      </div>
    </div>
    <div class="bg-gray mt-1">
      <div class="container">
        <a target="_blank" rel="sponsored noopener" style="text-decoration:none;display:inline-block;width:100%;" href="https://www.marketbeat.com/scripts/redirect.aspx?TriggeredCampaignID=10741&amp;UserID=13091940&amp;Placement=NativeDisplay&amp;Source=NativeDisplay&amp;interstitial=1&amp;noskip=1"><div class="row d-sm-flex c-green" style="font-weight:300;line-height:1.3;"><div class="col" style="float:left; -webkit-box-flex: 0; -ms-flex: 0 0 auto; flex: 0 0 auto; width: auto; max-width: none;"><div class="my-1 i-clipped lazy" style="width:153px; height:138px; padding: 0;background:url(&quot;https://s3.us-east-1.amazonaws.com/marketingassets.cloudsna.com/prod/images/brownstoneresearch/et/2024/11/Lift+2_BNF_Cybertruck_Jeff_Brown-01475.jpg&quot;);background-size:cover;background-position: center;max-width:23vw;max-height:20.75vw;"></div></div><div class="col pb-1" style="-webkit-box-flex: 1; -ms-flex: 1; flex: 1; width: auto; max-width: none;"><div class="pt-1"><div class="green-accent"></div><div class="h2 mt-1">Could This Tiny Device Help You Make an Extra $30k a Year?</div><div class="byline-size o-80" style="margin-bottom: 10px;"><span>From Brownstone Research &nbsp; | &nbsp; Ad</span></div><div style="clear:both;">I believe it’s going to power Elon Musk’s next AI revolution…

A revolution he believes will be worth more than $9 trillion.

That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. </div><div class="a-green a-dark-green mt-1">Click here to see the details because I believe a lot of people will get rich.</div></div></div></div></a><img
          loading="lazy" src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10741&amp;Placement=NativeDisplay&amp;Source=NativeDisplay" alt="" height="1" width="1">
      </div>
    </div>
    <div class="see-more-section">
      <div class="container" id="insider-trading-history">
        <h2>Centessa Pharmaceuticals Insider Trading History</h2>
        <table class="tdt sbt">
          <thead>
            <tr>
              <th data-sort="int">Transaction Date</th>
              <th data-sort="string">Insider Name</th>
              <th data-sort="string">Title</th>
              <th data-sort="string" style="min-width:54px;">Buy/Sell</th>
              <th data-sort="float">Number of Shares</th>
              <th data-sort="float">Average Share Price</th>
              <th data-sort="float">Total Transaction</th>
              <th data-sort="int">Shares Held After Transaction</th>
              <th>Details</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td data-sort="20241220000000">12/20/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>55,000</td>
              <td>$17.44</td>
              <td>$959,200.00</td>
              <td>520,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000186/xslF345X05/wk-form4_1734733345.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 55,000 Centessa Pharmaceuticals shares on 12/20/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241217000000">12/17/2024</td>
              <td>Karen M Anderson</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>10,624</td>
              <td>$17.32</td>
              <td>$184,007.68</td>
              <td>71,525</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1762176/000184790324000182/xslF345X05/wk-form4_1734473335.xml" target="_blank" title="View SEC Filing for Karen M Anderson’s Sell of 10,624 Centessa Pharmaceuticals shares on 12/17/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241217000000">12/17/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/tia-l-bush/">Tia L. Bush</a></td>
              <td>CTO</td>
              <td>Sell</td>
              <td>17,813</td>
              <td>$18.00</td>
              <td>$320,634.00</td>
              <td>147,615</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000184/xslF345X05/wk-form4_1734473465.xml" target="_blank" title="View SEC Filing for Tia L Bush’s Sell of 17,813 Centessa Pharmaceuticals shares on 12/17/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241216000000">12/16/2024</td>
              <td>Iqbal J Hussain</td>
              <td>General Counsel</td>
              <td>Sell</td>
              <td>77,705</td>
              <td>$16.39</td>
              <td>$1,273,584.95</td>
              <td>125,785</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000183/xslF345X05/wk-form4_1734473398.xml" target="_blank" title="View SEC Filing for Iqbal J Hussain’s Sell of 77,705 Centessa Pharmaceuticals shares on 12/16/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241213000000">12/13/2024</td>
              <td>Karen M Anderson</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>5,876</td>
              <td>$17.01</td>
              <td>$99,950.76</td>
              <td>71,525</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1762176/000184790324000182/xslF345X05/wk-form4_1734473335.xml" target="_blank" title="View SEC Filing for Karen M Anderson’s Sell of 5,876 Centessa Pharmaceuticals shares on 12/13/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241206000000">12/6/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>87,496</td>
              <td>$18.46</td>
              <td>$1,615,176.16</td>
              <td>575,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000178/xslF345X05/wk-form4_1733522614.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 87,496 Centessa Pharmaceuticals shares on 12/6/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241125000000">11/25/2024</td>
              <td>Gregory M Weinhoff</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>10,000</td>
              <td>$17.66</td>
              <td>$176,600.00</td>
              <td>183,266</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790324000173/xslF345X05/wk-form4_1732742424.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 10,000 Centessa Pharmaceuticals shares on 11/25/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241125000000">11/25/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>299</td>
              <td>$18.23</td>
              <td>$5,450.77</td>
              <td>575,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000175/xslF345X05/wk-form4_1732742538.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 299 Centessa Pharmaceuticals shares on 11/25/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241122000000">11/22/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>1,671</td>
              <td>$18.24</td>
              <td>$30,479.04</td>
              <td>575,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000171/xslF345X05/wk-form4_1732313158.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 1,671 Centessa Pharmaceuticals shares on 11/22/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241120000000">11/20/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>55,000</td>
              <td>$16.89</td>
              <td>$928,950.00</td>
              <td>575,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000171/xslF345X05/wk-form4_1732313158.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 55,000 Centessa Pharmaceuticals shares on 11/20/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241025000000">10/25/2024</td>
              <td>Gregory M Weinhoff</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>11,742</td>
              <td>$15.38</td>
              <td>$180,591.96</td>
              <td>183,266</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790324000162/xslF345X05/wk-form4_1729898384.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 11,742 Centessa Pharmaceuticals shares on 10/25/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241023000000">10/23/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>2,592</td>
              <td>$15.32</td>
              <td>$39,709.44</td>
              <td>630,661</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000160/xslF345X05/wk-form4_1729718836.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 2,592 Centessa Pharmaceuticals shares on 10/23/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20241021000000">10/21/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>22,205</td>
              <td>$15.80</td>
              <td>$350,839.00</td>
              <td>663,456</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000160/xslF345X05/wk-form4_1729718836.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 22,205 Centessa Pharmaceuticals shares on 10/21/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240925000000">9/25/2024</td>
              <td>Gregory M Weinhoff</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>16,619</td>
              <td>$15.69</td>
              <td>$260,752.11</td>
              <td>206,750</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790324000147/xslF345X05/wk-form4_1727468106.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 16,619 Centessa Pharmaceuticals shares on 9/25/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240920000000">9/20/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>55,000</td>
              <td>$16.53</td>
              <td>$909,150.00</td>
              <td>721,924</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000145/xslF345X05/wk-form4_1726865706.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 55,000 Centessa Pharmaceuticals shares on 9/20/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240910000000">9/10/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>175,000</td>
              <td>$16.52</td>
              <td>$2,891,000.00</td>
              <td>776,924</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000142/xslF345X05/wk-form4_1726185660.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 175,000 Centessa Pharmaceuticals shares on 9/10/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240909000000">9/9/2024</td>
              <td>Gregory M Weinhoff</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>25,000</td>
              <td>$15.00</td>
              <td>$375,000.00</td>
              <td>223,369</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790324000143/xslF345X05/wk-form4_1726185695.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 25,000 Centessa Pharmaceuticals shares on 9/9/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240822000000">8/22/2024</td>
              <td>Gregory M Weinhoff</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>12,198</td>
              <td>$12.17</td>
              <td>$148,449.66</td>
              <td>241,171</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790324000135/xslF345X05/wk-form4_1724447513.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 12,198 Centessa Pharmaceuticals shares on 8/22/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240822000000">8/22/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>506</td>
              <td>$12.23</td>
              <td>$6,188.38</td>
              <td>823,575</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000137/xslF345X05/wk-form4_1724447584.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 506 Centessa Pharmaceuticals shares on 8/22/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240820000000">8/20/2024</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Sell</td>
              <td>4,169</td>
              <td>$12.32</td>
              <td>$51,362.08</td>
              <td>827,755</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000131/xslF345X05/wk-form4_1724361323.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Sell of 4,169 Centessa Pharmaceuticals shares on 8/20/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240325000000">3/25/2024</td>
              <td>Karen M Anderson</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>51,160</td>
              <td>$11.88</td>
              <td>$607,780.80</td>
              <td>71,525</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1762176/000184790324000046/xslF345X05/wk-form4_1711484173.xml" target="_blank" title="View SEC Filing for Karen M Anderson’s Sell of 51,160 Centessa Pharmaceuticals shares on 3/25/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20240201000000">2/1/2024</td>
              <td>Harris Rotman</td>
              <td>SVP</td>
              <td>Sell</td>
              <td>4,267</td>
              <td>$8.10</td>
              <td>$34,562.70</td>
              <td>62,625</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790324000031/xslF345X05/wk-form4_1706911412.xml" target="_blank" title="View SEC Filing for Harris Rotman’s Sell of 4,267 Centessa Pharmaceuticals shares on 2/1/2024"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20230920000000">9/20/2023</td>
              <td>Harris Rotman</td>
              <td>SVP</td>
              <td>Sell</td>
              <td>37,484</td>
              <td>$6.29</td>
              <td>$235,774.36</td>
              <td>33,500</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790323000161/xslF345X05/wk-form4_1695415648.xml" target="_blank" title="View SEC Filing for Harris Rotman’s Sell of 37,484 Centessa Pharmaceuticals shares on 9/20/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20230601000000">6/1/2023</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>6,500</td>
              <td>$4.45</td>
              <td>$28,925.00</td>
              <td>783,066</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790323000104/xslF345X04/wf-form4_168573967509369.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 6,500 Centessa Pharmaceuticals shares on 6/1/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20230524000000">5/24/2023</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/tia-l-bush/">Tia L. Bush</a></td>
              <td>Insider</td>
              <td>Sell</td>
              <td>8,000</td>
              <td>$4.48</td>
              <td>$35,840.00</td>
              <td>157,102</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790323000102/xslF345X04/wf-form4_168513484084601.xml" target="_blank" title="View SEC Filing for Tia L Bush’s Sell of 8,000 Centessa Pharmaceuticals shares on 5/24/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20230501000000">5/1/2023</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>6,800</td>
              <td>$4.42</td>
              <td>$30,056.00</td>
              <td>789,566</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790323000090/xslF345X04/wf-form4_168306126573933.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 6,800 Centessa Pharmaceuticals shares on 5/1/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20230104000000">1/4/2023</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>6,970</td>
              <td>$3.18</td>
              <td>$22,164.60</td>
              <td>751,913</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790323000016/xslF345X03/wf-form4_167287861848269.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 6,970 Centessa Pharmaceuticals shares on 1/4/2023"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221201000000">12/1/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>9,400</td>
              <td>$3.91</td>
              <td>$36,754.00</td>
              <td>761,151</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000109/xslF345X03/wf-form4_167027612462669.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 9,400 Centessa Pharmaceuticals shares on 12/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221101000000">11/1/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>9,700</td>
              <td>$4.03</td>
              <td>$39,091.00</td>
              <td>765,059</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000076/xslF345X03/wf-form4_166750853622394.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 9,700 Centessa Pharmaceuticals shares on 11/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221003000000">10/3/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>12,524</td>
              <td>$3.92</td>
              <td>$49,094.08</td>
              <td>774,759</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000065/xslF345X03/wf-form4_166491712141879.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 12,524 Centessa Pharmaceuticals shares on 10/3/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221003000000">10/3/2022</td>
              <td>David M Chao</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>4,167</td>
              <td>$3.95</td>
              <td>$16,459.65</td>
              <td>222,932</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000062/xslF345X03/wf-form4_166491670138927.xml" target="_blank" title="View SEC Filing for David M Chao’s Sell of 4,167 Centessa Pharmaceuticals shares on 10/3/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221003000000">10/3/2022</td>
              <td>Gregory M Weinhoff</td>
              <td>CFO</td>
              <td>Sell</td>
              <td>4,901</td>
              <td>$3.95</td>
              <td>$19,358.95</td>
              <td>231,099</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790322000066/xslF345X03/wf-form4_166491735464077.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 4,901 Centessa Pharmaceuticals shares on 10/3/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221003000000">10/3/2022</td>
              <td>Iqbal J Hussain</td>
              <td>General Counsel</td>
              <td>Sell</td>
              <td>4,563</td>
              <td>$3.95</td>
              <td>$18,023.85</td>
              <td>154,712</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000064/xslF345X03/wf-form4_166491700237726.xml" target="_blank" title="View SEC Filing for Iqbal J Hussain’s Sell of 4,563 Centessa Pharmaceuticals shares on 10/3/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20221003000000">10/3/2022</td>
              <td>Thomas Templeman</td>
              <td>CTO</td>
              <td>Sell</td>
              <td>2,455</td>
              <td>$3.95</td>
              <td>$9,697.25</td>
              <td>135,792</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1654274/000184790322000068/xslF345X03/wf-form4_166491752809560.xml" target="_blank" title="View SEC Filing for Thomas Templeman’s Sell of 2,455 Centessa Pharmaceuticals shares on 10/3/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220930000000">9/30/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>2,468</td>
              <td>$4.07</td>
              <td>$10,044.76</td>
              <td>787,283</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000065/xslF345X03/wf-form4_166491712141879.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 2,468 Centessa Pharmaceuticals shares on 9/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220930000000">9/30/2022</td>
              <td>David M Chao</td>
              <td>Insider</td>
              <td>Sell</td>
              <td>3,401</td>
              <td>$4.07</td>
              <td>$13,842.07</td>
              <td>227,099</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000062/xslF345X03/wf-form4_166491670138927.xml" target="_blank" title="View SEC Filing for David M Chao’s Sell of 3,401 Centessa Pharmaceuticals shares on 9/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220930000000">9/30/2022</td>
              <td>Gregory M Weinhoff</td>
              <td>CFO</td>
              <td>Sell</td>
              <td>4,000</td>
              <td>$4.07</td>
              <td>$16,280.00</td>
              <td>236,000</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1400975/000184790322000066/xslF345X03/wf-form4_166491735464077.xml" target="_blank" title="View SEC Filing for Gregory M Weinhoff’s Sell of 4,000 Centessa Pharmaceuticals shares on 9/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220930000000">9/30/2022</td>
              <td>Iqbal J Hussain</td>
              <td>General Counsel</td>
              <td>Sell</td>
              <td>3,725</td>
              <td>$4.07</td>
              <td>$15,160.75</td>
              <td>159,275</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000184790322000064/xslF345X03/wf-form4_166491700237726.xml" target="_blank" title="View SEC Filing for Iqbal J Hussain’s Sell of 3,725 Centessa Pharmaceuticals shares on 9/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220930000000">9/30/2022</td>
              <td>Thomas Templeman</td>
              <td>CTO</td>
              <td>Sell</td>
              <td>2,003</td>
              <td>$4.07</td>
              <td>$8,152.21</td>
              <td>138,247</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1654274/000184790322000068/xslF345X03/wf-form4_166491752809560.xml" target="_blank" title="View SEC Filing for Thomas Templeman’s Sell of 2,003 Centessa Pharmaceuticals shares on 9/30/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220801000000">8/1/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>10,423</td>
              <td>$4.45</td>
              <td>$46,382.35</td>
              <td>800,174</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322027633/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 10,423 Centessa Pharmaceuticals shares on 8/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220718000000">7/18/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>20,000</td>
              <td>$4.87</td>
              <td>$97,400.00</td>
              <td>810,597</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322026421/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 20,000 Centessa Pharmaceuticals shares on 7/18/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220701000000">7/1/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>9,100</td>
              <td>$5.03</td>
              <td>$45,773.00</td>
              <td>730,597</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322025479/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 9,100 Centessa Pharmaceuticals shares on 7/1/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220624000000">6/24/2022</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Buy</td>
              <td>10,000</td>
              <td>$4.63</td>
              <td>$46,300.00</td>
              <td>38,000</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322024303/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Buy of 10,000 Centessa Pharmaceuticals shares on 6/24/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220617000000">6/17/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>9,200</td>
              <td>$4.68</td>
              <td>$43,056.00</td>
              <td>739,697</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322023485/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 9,200 Centessa Pharmaceuticals shares on 6/17/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220517000000">5/17/2022</td>
              <td>Antoine Yver</td>
              <td>EVP</td>
              <td>Sell</td>
              <td>20,222</td>
              <td>$5.42</td>
              <td>$109,603.24</td>
              <td>813,675</td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322018913/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Antoine Yver’s Sell of 20,222 Centessa Pharmaceuticals shares on 5/17/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220202000000">2/2/2022</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/saurabh-saha/">Saurabh Saha</a></td>
              <td>CEO</td>
              <td>Buy</td>
              <td>5,000</td>
              <td>$9.74</td>
              <td>$48,700.00</td>
              <td></td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322004782/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for Saurabh Saha’s Buy of 5,000 Centessa Pharmaceuticals shares on 2/2/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
            <tr>
              <td data-sort="20220128000000">1/28/2022</td>
              <td><a href="/centessa-pharmaceuticals-plc-american-depositary-shares-stock/david-j-grainger/">David J. Grainger</a></td>
              <td>Insider</td>
              <td>Buy</td>
              <td>27,500</td>
              <td>$9.05</td>
              <td>$248,875.00</td>
              <td></td>
              <td>
                <a rel="nofollow noopener" href="https://www.sec.gov/Archives/edgar/data/1847903/000089924322003924/xslF345X03/doc4.xml" target="_blank" title="View SEC Filing for David J Grainger’s Buy of 27,500 Centessa Pharmaceuticals shares on 1/28/2022"><img src="/images/insider-trades-icon-details.svg?v=2" width="27" height="27" alt="View SEC Filing Icon" loading="lazy"></a>&nbsp;&nbsp;
              </td>
            </tr>
          </tbody>
        </table>
      </div>
      <div class="see-more-fade d-none">
        <div class="container see-more-fade-inner">
          <div class="c-blue see-more-button button">See Full Table</div>
        </div>
      </div>
    </div>
    <div class="bg-gray mt-1">
      <div class="container">
        <a target="_blank" rel="sponsored noopener" style="text-decoration:none;display:inline-block;width:100%;" href="https://www.marketbeat.com/scripts/redirect.aspx?TriggeredCampaignID=11076&amp;UserID=13091940&amp;Placement=NativeDisplay&amp;Source=NativeDisplay&amp;interstitial=1&amp;noskip=1"><div class="row d-sm-flex c-green" style="font-weight:300;line-height:1.3;"><div class="col" style="float:left; -webkit-box-flex: 0; -ms-flex: 0 0 auto; flex: 0 0 auto; width: auto; max-width: none;"><div class="my-1 i-clipped lazy" style="width:153px; height:138px; padding: 0;background:url(&quot;https://image.exct.tradesmith.com/lib/fe8213727c6200757c/m/1/69befeb0-b017-4aeb-9afc-9f467c166e1f.png&quot;);background-size:cover;background-position: center;max-width:23vw;max-height:20.75vw;"></div></div><div class="col pb-1" style="-webkit-box-flex: 1; -ms-flex: 1; flex: 1; width: auto; max-width: none;"><div class="pt-1"><div class="green-accent"></div><div class="h2 mt-1">Wall St. Icon: “If you wait on this, it will already be too late”</div><div class="byline-size o-80" style="margin-bottom: 10px;"><span>From InvestorPlace &nbsp; | &nbsp; Ad</span></div><div style="clear:both;">If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research. </div><div class="a-green a-dark-green mt-1">Go here now to see my urgent warning</div></div></div></div></a><img
          loading="lazy" src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=11076&amp;Placement=NativeDisplay&amp;Source=NativeDisplay" alt="" height="1" width="1">
      </div>
    </div>
    <div class="container">
      <h2 id="sec-filings">SEC Filings (Institutional Ownership Changes) for Centessa Pharmaceuticals (NASDAQ:CNTA)</h2>
      <p>82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.</p>
      <h3 class="h4">Institutional Buying and Selling by Quarter</h3>
      <p class="sr-only">This chart shows the instiutional buying and selling at CNTA by year and by quarter.</p>
      <a href="#company-description" class="sr-only sr-only-focusable">Skip Institutional Buying and Selling Chart and Table Data</a><a href="#institutional-trading-history" class="sr-only sr-only-focusable">Read Chart Data in Institutional Trading History Table</a>
      <div id="SECChart" class="dv-chart" style="height:350px"></div>
    </div>
    <div class="see-more-section">
      <div class="container" id="institutional-trading-history">
        <h3>Centessa Pharmaceuticals Institutional Trading History</h3>
        <table class="tdt sbt">
          <thead>
            <tr>
              <th data-sort="int">Reporting Date</th>
              <th data-sort="string">Hedge Fund</th>
              <th data-sort="float">Shares Held</th>
              <th data-sort="float">Market Value</th>
              <th data-sort="float">% of Portfolio</th>
              <th data-sort="float">Quarterly Change in Shares</th>
              <th data-sort="float">Ownership in Company</th>
              <th>Details</th>
            </tr>
          </thead>
          <tbody>
            <tr class="even">
              <td data-sort="20241213000000">12/13/2024</td>
              <td>Lord Abbett &amp; CO. LLC</td>
              <td>269,205</td>
              <td data-sort="4305000">$4.31M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.204%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Lord+Abbett++CO.+LLC+13F SEC" title="Search for Lord Abbett &amp; CO. LLC’s 12/13/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241213000000">12/13/2024</td>
              <td>Exome Asset Management LLC</td>
              <td>138,152</td>
              <td data-sort="2209000">$2.21M</td>
              <td>1.5%</td>
              <td class="c-red" data-sort="-49.7%">-49.7%</td>
              <td>0.105%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Exome+Asset+Management+LLC+13F SEC" title="Search for Exome Asset Management LLC’s 12/13/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241127000000">11/27/2024</td>
              <td>Franklin Resources Inc.</td>
              <td>2,302,546</td>
              <td data-sort="38360000">$38.36M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="99.1%">+99.1%</td>
              <td>1.746%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Franklin+Resources+Inc.+13F SEC" title="Search for Franklin Resources Inc.’s 11/27/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241116000000">11/16/2024</td>
              <td>Geode Capital Management LLC</td>
              <td>56,597</td>
              <td data-sort="905000">$0.91M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="68.7%">+68.7%</td>
              <td>0.050%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Geode+Capital+Management+LLC+13F SEC" title="Search for Geode Capital Management LLC’s 11/16/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>XTX Topco Ltd</td>
              <td>10,174</td>
              <td data-sort="163000">$0.16M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-37.9%">-37.9%</td>
              <td>0.009%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=XTX+Topco+Ltd+13F SEC" title="Search for XTX Topco Ltd’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>Jane Street Group LLC</td>
              <td>177,260</td>
              <td data-sort="2834000">$2.83M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.156%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Jane+Street+Group+LLC+13F SEC" title="Search for Jane Street Group LLC’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>Wellington Management Group LLP</td>
              <td>100,613</td>
              <td data-sort="1609000">$1.61M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.089%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Wellington+Management+Group+LLP+13F SEC" title="Search for Wellington Management Group LLP’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>State Street Corp</td>
              <td>48,592</td>
              <td data-sort="777000">$0.78M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.043%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=State+Street+Corp+13F SEC" title="Search for State Street Corp’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>RTW Investments LP</td>
              <td>50,000</td>
              <td data-sort="800000">$0.80M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.044%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=RTW+Investments+LP+13F SEC" title="Search for RTW Investments LP’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>Point72 Asset Management L.P.</td>
              <td>2,715,663</td>
              <td data-sort="43423000">$43.42M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="54.1%">+54.1%</td>
              <td>2.397%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Asset+Management+L.P.+13F SEC" title="Search for Point72 Asset Management L.P.’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>Janus Henderson Group PLC</td>
              <td>1,294,864</td>
              <td data-sort="20698000">$20.70M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>1.143%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Janus+Henderson+Group+PLC+13F SEC" title="Search for Janus Henderson Group PLC’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>HighVista Strategies LLC</td>
              <td>46,116</td>
              <td data-sort="737000">$0.74M</td>
              <td>0.3%</td>
              <td data-sort="0">N/A</td>
              <td>0.041%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=HighVista+Strategies+LLC+13F SEC" title="Search for HighVista Strategies LLC’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241115000000">11/15/2024</td>
              <td>Baker BROS. Advisors LP</td>
              <td>1,227,178</td>
              <td data-sort="19623000">$19.62M</td>
              <td>0.2%</td>
              <td class="c-green" data-sort="123.4%">+123.4%</td>
              <td>1.083%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Baker+BROS.+Advisors+LP+13F SEC" title="Search for Baker BROS. Advisors LP’s 11/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241114000000">11/14/2024</td>
              <td>PFM Health Sciences LP</td>
              <td>269,158</td>
              <td data-sort="4304000">$4.30M</td>
              <td>0.2%</td>
              <td class="c-red" data-sort="-57.7%">-57.7%</td>
              <td>0.238%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=PFM+Health+Sciences+LP+13F SEC" title="Search for PFM Health Sciences LP’s 11/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241114000000">11/14/2024</td>
              <td>Fred Alger Management LLC</td>
              <td>177,553</td>
              <td data-sort="2839000">$2.84M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="1,515.1%">+1,515.1%</td>
              <td>0.157%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Fred+Alger+Management+LLC+13F SEC" title="Search for Fred Alger Management LLC’s 11/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241114000000">11/14/2024</td>
              <td>Walleye Capital LLC</td>
              <td>11,721</td>
              <td data-sort="187000">$0.19M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.010%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Walleye+Capital+LLC+13F SEC" title="Search for Walleye Capital LLC’s 11/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241114000000">11/14/2024</td>
              <td>Suvretta Capital Management LLC</td>
              <td>70,000</td>
              <td data-sort="1119000">$1.12M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.062%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Suvretta+Capital+Management+LLC+13F SEC" title="Search for Suvretta Capital Management LLC’s 11/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241114000000">11/14/2024</td>
              <td>Ally Bridge Group NY LLC</td>
              <td>309,614</td>
              <td data-sort="4951000">$4.95M</td>
              <td>2.7%</td>
              <td data-sort="0">N/A</td>
              <td>0.273%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Ally+Bridge+Group+NY+LLC+13F SEC" title="Search for Ally Bridge Group NY LLC’s 11/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241113000000">11/13/2024</td>
              <td>FMR LLC</td>
              <td>2,916,494</td>
              <td data-sort="46635000">$46.64M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="4.6%">+4.6%</td>
              <td>2.574%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=FMR+LLC+13F SEC" title="Search for FMR LLC’s 11/13/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241113000000">11/13/2024</td>
              <td>The Manufacturers Life Insurance Company</td>
              <td>264,969</td>
              <td data-sort="4237000">$4.24M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="88.1%">+88.1%</td>
              <td>0.234%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=The+Manufacturers+Life+Insurance+Company+13F SEC" title="Search for The Manufacturers Life Insurance Company’s 11/13/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241105000000">11/5/2024</td>
              <td>GSA Capital Partners LLP</td>
              <td>93,658</td>
              <td data-sort="1498000">$1.50M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="66.1%">+66.1%</td>
              <td>0.083%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=GSA+Capital+Partners+LLP+13F SEC" title="Search for GSA Capital Partners LLP’s 11/5/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241101000000">11/1/2024</td>
              <td>Atria Investments Inc</td>
              <td>17,134</td>
              <td data-sort="274000">$0.27M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="7.0%">+7.0%</td>
              <td>0.015%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Atria+Investments+Inc+13F SEC" title="Search for Atria Investments Inc’s 11/1/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241025000000">10/25/2024</td>
              <td>China Universal Asset Management Co. Ltd.</td>
              <td>13,593</td>
              <td data-sort="217000">$0.22M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="99.7%">+99.7%</td>
              <td>0.014%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=China+Universal+Asset+Management+Co.+Ltd.+13F SEC" title="Search for China Universal Asset Management Co. Ltd.’s 10/25/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241023000000">10/23/2024</td>
              <td>Mirae Asset Global Investments Co. Ltd.</td>
              <td>2,556</td>
              <td data-sort="40000">$40K</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="47.7%">+47.7%</td>
              <td>0.003%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Mirae+Asset+Global+Investments+Co.+Ltd.+13F SEC" title="Search for Mirae Asset Global Investments Co. Ltd.’s 10/23/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20241017000000">10/17/2024</td>
              <td>Harbour Capital Advisors LLC</td>
              <td>16,675</td>
              <td data-sort="259000">$0.26M</td>
              <td>0.1%</td>
              <td data-sort="0">N/A</td>
              <td>0.017%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Harbour+Capital+Advisors+LLC+13F SEC" title="Search for Harbour Capital Advisors LLC’s 10/17/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20241007000000">10/7/2024</td>
              <td>GAMMA Investing LLC</td>
              <td>2,972</td>
              <td data-sort="48000">$48K</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="103.1%">+103.1%</td>
              <td>0.003%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=GAMMA+Investing+LLC+13F SEC" title="Search for GAMMA Investing LLC’s 10/7/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240916000000">9/16/2024</td>
              <td>Cubist Systematic Strategies LLC</td>
              <td>26,073</td>
              <td data-sort="235000">$0.24M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-64.1%">-64.1%</td>
              <td>0.026%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Cubist+Systematic+Strategies+LLC+13F SEC" title="Search for Cubist Systematic Strategies LLC’s 9/16/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240820000000">8/20/2024</td>
              <td>Nantahala Capital Management LLC</td>
              <td>450,000</td>
              <td data-sort="4064000">$4.06M</td>
              <td>0.2%</td>
              <td data-sort="0">N/A</td>
              <td>0.448%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Nantahala+Capital+Management+LLC+13F SEC" title="Search for Nantahala Capital Management LLC’s 8/20/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240819000000">8/19/2024</td>
              <td>Point72 Asset Management L.P.</td>
              <td>1,762,004</td>
              <td data-sort="15911000">$15.91M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-22.0%">-22.0%</td>
              <td>1.754%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Asset+Management+L.P.+13F SEC" title="Search for Point72 Asset Management L.P.’s 8/19/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240816000000">8/16/2024</td>
              <td>Perceptive Advisors LLC</td>
              <td>3,933,307</td>
              <td data-sort="35518000">$35.52M</td>
              <td>0.8%</td>
              <td class="c-green" data-sort="27.6%">+27.6%</td>
              <td>3.914%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Perceptive+Advisors+LLC+13F SEC" title="Search for Perceptive Advisors LLC’s 8/16/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240816000000">8/16/2024</td>
              <td>Quarry LP</td>
              <td>9,608</td>
              <td data-sort="87000">$87K</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="47.8%">+47.8%</td>
              <td>0.010%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Quarry+LP+13F SEC" title="Search for Quarry LP’s 8/16/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240816000000">8/16/2024</td>
              <td>Driehaus Capital Management LLC</td>
              <td>2,092,011</td>
              <td data-sort="18891000">$18.89M</td>
              <td>0.2%</td>
              <td class="c-green" data-sort="89.5%">+89.5%</td>
              <td>2.082%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Driehaus+Capital+Management+LLC+13F SEC" title="Search for Driehaus Capital Management LLC’s 8/16/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240815000000">8/15/2024</td>
              <td>The Manufacturers Life Insurance Company</td>
              <td>140,894</td>
              <td data-sort="1272000">$1.27M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="30.4%">+30.4%</td>
              <td>0.140%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=The+Manufacturers+Life+Insurance+Company+13F SEC" title="Search for The Manufacturers Life Insurance Company’s 8/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240815000000">8/15/2024</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>1,135,702</td>
              <td data-sort="10255000">$10.26M</td>
              <td>1.2%</td>
              <td class="c-green" data-sort="36.7%">+36.7%</td>
              <td>1.130%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 8/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>Fred Alger Management LLC</td>
              <td>10,993</td>
              <td data-sort="99000">$99K</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.011%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Fred+Alger+Management+LLC+13F SEC" title="Search for Fred Alger Management LLC’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>Sandia Investment Management LP</td>
              <td>10,000</td>
              <td data-sort="90000">$90K</td>
              <td>0.1%</td>
              <td data-sort="0">N/A</td>
              <td>0.010%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Sandia+Investment+Management+LP+13F SEC" title="Search for Sandia Investment Management LP’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>Cubist Systematic Strategies LLC</td>
              <td>26,073</td>
              <td data-sort="235000">$0.24M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-64.1%">-64.1%</td>
              <td>0.026%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Cubist+Systematic+Strategies+LLC+13F SEC" title="Search for Cubist Systematic Strategies LLC’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>First Light Asset Management LLC</td>
              <td>4,780,560</td>
              <td data-sort="43168000">$43.17M</td>
              <td>3.8%</td>
              <td class="c-green" data-sort="59.2%">+59.2%</td>
              <td>4.758%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=First+Light+Asset+Management+LLC+13F SEC" title="Search for First Light Asset Management LLC’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>Marshall Wace LLP</td>
              <td>224,948</td>
              <td data-sort="2031000">$2.03M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-2.9%">-2.9%</td>
              <td>0.224%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Marshall+Wace+LLP+13F SEC" title="Search for Marshall Wace LLP’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240814000000">8/14/2024</td>
              <td>Farallon Capital Management LLC</td>
              <td>1,996,000</td>
              <td data-sort="18024000">$18.02M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="438.0%">+438.0%</td>
              <td>1.986%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Farallon+Capital+Management+LLC+13F SEC" title="Search for Farallon Capital Management LLC’s 8/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240812000000">8/12/2024</td>
              <td>XTX Topco Ltd</td>
              <td>16,385</td>
              <td data-sort="148000">$0.15M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.016%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=XTX+Topco+Ltd+13F SEC" title="Search for XTX Topco Ltd’s 8/12/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240809000000">8/9/2024</td>
              <td>Renaissance Technologies LLC</td>
              <td>173,700</td>
              <td data-sort="1569000">$1.57M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-20.6%">-20.6%</td>
              <td>0.173%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Renaissance+Technologies+LLC+13F SEC" title="Search for Renaissance Technologies LLC’s 8/9/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240808000000">8/8/2024</td>
              <td>American Century Companies Inc.</td>
              <td>935,151</td>
              <td data-sort="8444000">$8.44M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="1.3%">+1.3%</td>
              <td>0.931%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=American+Century+Companies+Inc.+13F SEC" title="Search for American Century Companies Inc.’s 8/8/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240803000000">8/3/2024</td>
              <td>TD Asset Management Inc</td>
              <td>321,168</td>
              <td data-sort="2900000">$2.90M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="40.5%">+40.5%</td>
              <td>0.320%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=TD+Asset+Management+Inc+13F SEC" title="Search for TD Asset Management Inc’s 8/3/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240729000000">7/29/2024</td>
              <td>HighMark Wealth Management LLC</td>
              <td>93,000</td>
              <td data-sort="840000">$0.84M</td>
              <td>0.5%</td>
              <td data-sort="0">N/A</td>
              <td>0.093%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=HighMark+Wealth+Management+LLC+13F SEC" title="Search for HighMark Wealth Management LLC’s 7/29/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240530000000">5/30/2024</td>
              <td>Lynx1 Capital Management LP</td>
              <td>17,400</td>
              <td data-sort="197000">$0.20M</td>
              <td>0.1%</td>
              <td data-sort="0">N/A</td>
              <td>0.017%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Lynx1+Capital+Management+LP+13F SEC" title="Search for Lynx1 Capital Management LP’s 5/30/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240524000000">5/24/2024</td>
              <td>Farallon Capital Management LLC</td>
              <td>371,000</td>
              <td data-sort="4192000">$4.19M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.369%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Farallon+Capital+Management+LLC+13F SEC" title="Search for Farallon Capital Management LLC’s 5/24/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240517000000">5/17/2024</td>
              <td>Artal Group S.A.</td>
              <td>1,412,500</td>
              <td data-sort="15961000">$15.96M</td>
              <td>0.4%</td>
              <td class="c-green" data-sort="39.5%">+39.5%</td>
              <td>1.250%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Artal+Group+S.A.+13F SEC" title="Search for Artal Group S.A.’s 5/17/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240515000000">5/15/2024</td>
              <td>First Light Asset Management LLC</td>
              <td>3,002,045</td>
              <td data-sort="33923000">$33.92M</td>
              <td>2.6%</td>
              <td data-sort="0">N/A</td>
              <td>2.980%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=First+Light+Asset+Management+LLC+13F SEC" title="Search for First Light Asset Management LLC’s 5/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240515000000">5/15/2024</td>
              <td>Price T Rowe Associates Inc. MD</td>
              <td>2,958,079</td>
              <td data-sort="33427000">$33.43M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="16.5%">+16.5%</td>
              <td>2.936%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Price+T+Rowe+Associates+Inc.+MD+13F SEC" title="Search for Price T Rowe Associates Inc. MD’s 5/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240515000000">5/15/2024</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>830,546</td>
              <td data-sort="9385000">$9.39M</td>
              <td>1.2%</td>
              <td class="c-green" data-sort="4.4%">+4.4%</td>
              <td>0.824%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 5/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240514000000">5/14/2024</td>
              <td>EntryPoint Capital LLC</td>
              <td>9,636</td>
              <td data-sort="109000">$0.11M</td>
              <td>0.1%</td>
              <td data-sort="0">N/A</td>
              <td>0.010%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=EntryPoint+Capital+LLC+13F SEC" title="Search for EntryPoint Capital LLC’s 5/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240514000000">5/14/2024</td>
              <td>Platinum Investment Management Ltd.</td>
              <td>485,174</td>
              <td data-sort="5482000">$5.48M</td>
              <td>0.2%</td>
              <td class="c-green" data-sort="27.3%">+27.3%</td>
              <td>0.482%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Platinum+Investment+Management+Ltd.+13F SEC" title="Search for Platinum Investment Management Ltd.’s 5/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240510000000">5/10/2024</td>
              <td>Acadian Asset Management LLC</td>
              <td>29,409</td>
              <td data-sort="330000">$0.33M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.029%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Acadian+Asset+Management+LLC+13F SEC" title="Search for Acadian Asset Management LLC’s 5/10/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240429000000">4/29/2024</td>
              <td>China Universal Asset Management Co. Ltd.</td>
              <td>10,817</td>
              <td data-sort="122000">$0.12M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="69.2%">+69.2%</td>
              <td>0.011%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=China+Universal+Asset+Management+Co.+Ltd.+13F SEC" title="Search for China Universal Asset Management Co. Ltd.’s 4/29/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240220000000">2/20/2024</td>
              <td>Quarry LP</td>
              <td>6,000</td>
              <td data-sort="48000">$48K</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.006%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Quarry+LP+13F SEC" title="Search for Quarry LP’s 2/20/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240215000000">2/15/2024</td>
              <td>Octagon Capital Advisors LP</td>
              <td>2,060,100</td>
              <td data-sort="16398000">$16.40M</td>
              <td>2.6%</td>
              <td class="c-green" data-sort="333.2%">+333.2%</td>
              <td>2.110%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Octagon+Capital+Advisors+LP+13F SEC" title="Search for Octagon Capital Advisors LP’s 2/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240215000000">2/15/2024</td>
              <td>BVF Inc. IL</td>
              <td>8,774,570</td>
              <td data-sort="69846000">$69.85M</td>
              <td>1.8%</td>
              <td class="c-red" data-sort="-3.6%">-3.6%</td>
              <td>8.988%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=BVF+Inc.+IL+13F SEC" title="Search for BVF Inc. IL’s 2/15/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240214000000">2/14/2024</td>
              <td>Kynam Capital Management LP</td>
              <td>442,704</td>
              <td data-sort="3524000">$3.52M</td>
              <td>0.4%</td>
              <td class="c-red" data-sort="-39.4%">-39.4%</td>
              <td>0.453%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Kynam+Capital+Management+LP+13F SEC" title="Search for Kynam Capital Management LP’s 2/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240214000000">2/14/2024</td>
              <td>Platinum Investment Management Ltd.</td>
              <td>381,083</td>
              <td data-sort="3033000">$3.03M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="12.9%">+12.9%</td>
              <td>0.390%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Platinum+Investment+Management+Ltd.+13F SEC" title="Search for Platinum Investment Management Ltd.’s 2/14/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240213000000">2/13/2024</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>795,729</td>
              <td data-sort="6334000">$6.33M</td>
              <td>1.2%</td>
              <td class="c-red" data-sort="-21.8%">-21.8%</td>
              <td>0.815%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 2/13/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240209000000">2/9/2024</td>
              <td>Franklin Resources Inc.</td>
              <td>1,115,817</td>
              <td data-sort="8882000">$8.88M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="34.1%">+34.1%</td>
              <td>1.143%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Franklin+Resources+Inc.+13F SEC" title="Search for Franklin Resources Inc.’s 2/9/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240209000000">2/9/2024</td>
              <td>Trexquant Investment LP</td>
              <td>14,354</td>
              <td data-sort="114000">$0.11M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.015%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Trexquant+Investment+LP+13F SEC" title="Search for Trexquant Investment LP’s 2/9/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20240207000000">2/7/2024</td>
              <td>Jump Financial LLC</td>
              <td>14,300</td>
              <td data-sort="114000">$0.11M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.015%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Jump+Financial+LLC+13F SEC" title="Search for Jump Financial LLC’s 2/7/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20240124000000">1/24/2024</td>
              <td>China Universal Asset Management Co. Ltd.</td>
              <td>6,394</td>
              <td data-sort="51000">$51K</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="371.2%">+371.2%</td>
              <td>0.007%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=China+Universal+Asset+Management+Co.+Ltd.+13F SEC" title="Search for China Universal Asset Management Co. Ltd.’s 1/24/2024 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20231115000000">11/15/2023</td>
              <td>Kynam Capital Management LP</td>
              <td>730,472</td>
              <td data-sort="4726000">$4.73M</td>
              <td>0.8%</td>
              <td class="c-green" data-sort="0.2%">+0.2%</td>
              <td>0.768%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Kynam+Capital+Management+LP+13F SEC" title="Search for Kynam Capital Management LP’s 11/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20231115000000">11/15/2023</td>
              <td>Acuta Capital Partners LLC</td>
              <td>323,349</td>
              <td data-sort="2092000">$2.09M</td>
              <td>1.4%</td>
              <td data-sort="0">N/A</td>
              <td>0.340%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Acuta+Capital+Partners+LLC+13F SEC" title="Search for Acuta Capital Partners LLC’s 11/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20231115000000">11/15/2023</td>
              <td>Adage Capital Partners GP L.L.C.</td>
              <td>2,830,500</td>
              <td data-sort="18313000">$18.31M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="25.8%">+25.8%</td>
              <td>2.974%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Adage+Capital+Partners+GP+L.L.C.+13F SEC" title="Search for Adage Capital Partners GP L.L.C.’s 11/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20231115000000">11/15/2023</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>1,018,091</td>
              <td data-sort="6587000">$6.59M</td>
              <td>1.9%</td>
              <td class="c-green" data-sort="13.0%">+13.0%</td>
              <td>1.045%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 11/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20231113000000">11/13/2023</td>
              <td>Rathbones Group PLC</td>
              <td>31,300</td>
              <td data-sort="203000">$0.20M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.032%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Rathbones+Group+PLC+13F SEC" title="Search for Rathbones Group PLC’s 11/13/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20231103000000">11/3/2023</td>
              <td>Platinum Investment Management Ltd.</td>
              <td>337,544</td>
              <td data-sort="2184000">$2.18M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="96.7%">+96.7%</td>
              <td>0.347%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Platinum+Investment+Management+Ltd.+13F SEC" title="Search for Platinum Investment Management Ltd.’s 11/3/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20231027000000">10/27/2023</td>
              <td>TD Asset Management Inc</td>
              <td>186,310</td>
              <td data-sort="1205000">$1.21M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="127.1%">+127.1%</td>
              <td>0.191%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=TD+Asset+Management+Inc+13F SEC" title="Search for TD Asset Management Inc’s 10/27/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20230821000000">8/21/2023</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>900,723</td>
              <td data-sort="5575000">$5.58M</td>
              <td>1.9%</td>
              <td class="c-green" data-sort="31.7%">+31.7%</td>
              <td>0.947%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 8/21/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20230811000000">8/11/2023</td>
              <td>Platinum Investment Management Ltd.</td>
              <td>171,625</td>
              <td data-sort="1062000">$1.06M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.180%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Platinum+Investment+Management+Ltd.+13F SEC" title="Search for Platinum Investment Management Ltd.’s 8/11/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20230803000000">8/3/2023</td>
              <td>Tanager Wealth Management LLP</td>
              <td>696,096</td>
              <td data-sort="4309000">$4.31M</td>
              <td>0.9%</td>
              <td class="c-red" data-sort="-5.6%">-5.6%</td>
              <td>0.728%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Tanager+Wealth+Management+LLP+13F SEC" title="Search for Tanager Wealth Management LLP’s 8/3/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20230516000000">5/16/2023</td>
              <td>BVF Inc. IL</td>
              <td>9,423,215</td>
              <td data-sort="36279000">$36.28M</td>
              <td>1.3%</td>
              <td class="c-green" data-sort="36.7%">+36.7%</td>
              <td>9.961%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=BVF+Inc.+IL+13F SEC" title="Search for BVF Inc. IL’s 5/16/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20230515000000">5/15/2023</td>
              <td>Affinity Asset Advisors LLC</td>
              <td>684,127</td>
              <td data-sort="2634000">$2.63M</td>
              <td>0.9%</td>
              <td class="c-green" data-sort="48.6%">+48.6%</td>
              <td>0.723%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Affinity+Asset+Advisors+LLC+13F SEC" title="Search for Affinity Asset Advisors LLC’s 5/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20230515000000">5/15/2023</td>
              <td>EcoR1 Capital LLC</td>
              <td>5,618,779</td>
              <td data-sort="21632000">$21.63M</td>
              <td>0.7%</td>
              <td class="c-green" data-sort="7.4%">+7.4%</td>
              <td>5.939%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=EcoR1+Capital+LLC+13F SEC" title="Search for EcoR1 Capital LLC’s 5/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20230515000000">5/15/2023</td>
              <td>Sio Capital Management LLC</td>
              <td>347,869</td>
              <td data-sort="1339000">$1.34M</td>
              <td>0.7%</td>
              <td data-sort="0">N/A</td>
              <td>0.368%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Sio+Capital+Management+LLC+13F SEC" title="Search for Sio Capital Management LLC’s 5/15/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20230418000000">4/18/2023</td>
              <td>Tanager Wealth Management LLP</td>
              <td>737,059</td>
              <td data-sort="2838000">$2.84M</td>
              <td>0.7%</td>
              <td class="c-red" data-sort="-60.8%">-60.8%</td>
              <td>0.779%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Tanager+Wealth+Management+LLP+13F SEC" title="Search for Tanager Wealth Management LLP’s 4/18/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20230214000000">2/14/2023</td>
              <td>EcoR1 Capital LLC</td>
              <td>5,232,279</td>
              <td data-sort="16220000">$16.22M</td>
              <td>0.5%</td>
              <td class="c-green" data-sort="61.7%">+61.7%</td>
              <td>5.531%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=EcoR1+Capital+LLC+13F SEC" title="Search for EcoR1 Capital LLC’s 2/14/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20230127000000">1/27/2023</td>
              <td>Tanager Wealth Management LLP</td>
              <td>1,878,383</td>
              <td data-sort="5823000">$5.82M</td>
              <td>1.6%</td>
              <td data-sort="0">N/A</td>
              <td>1.986%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Tanager+Wealth+Management+LLP+13F SEC" title="Search for Tanager Wealth Management LLP’s 1/27/2023 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20221115000000">11/15/2022</td>
              <td>Kynam Capital Management LP</td>
              <td>731,521</td>
              <td data-sort="2941000">$2.94M</td>
              <td>0.6%</td>
              <td class="c-red" data-sort="-3.5%">-3.5%</td>
              <td>0.775%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Kynam+Capital+Management+LP+13F SEC" title="Search for Kynam Capital Management LP’s 11/15/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20221115000000">11/15/2022</td>
              <td>EcoR1 Capital LLC</td>
              <td>3,236,352</td>
              <td data-sort="13010000">$13.01M</td>
              <td>0.4%</td>
              <td class="c-green" data-sort="1,007.1%">+1,007.1%</td>
              <td>3.431%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=EcoR1+Capital+LLC+13F SEC" title="Search for EcoR1 Capital LLC’s 11/15/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20221115000000">11/15/2022</td>
              <td>Ensign Peak Advisors Inc</td>
              <td>248,228</td>
              <td data-sort="998000">$1M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="101.7%">+101.7%</td>
              <td>0.263%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Ensign+Peak+Advisors+Inc+13F SEC" title="Search for Ensign Peak Advisors Inc’s 11/15/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20221114000000">11/14/2022</td>
              <td>Cormorant Asset Management LP</td>
              <td>1,972,728</td>
              <td data-sort="7930000">$7.93M</td>
              <td>0.6%</td>
              <td class="c-red" data-sort="-32.6%">-32.6%</td>
              <td>2.091%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Cormorant+Asset+Management+LP+13F SEC" title="Search for Cormorant Asset Management LP’s 11/14/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20221114000000">11/14/2022</td>
              <td>Point72 Asset Management L.P.</td>
              <td>117,800</td>
              <td data-sort="474000">$0.47M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-11.8%">-11.8%</td>
              <td>0.125%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Asset+Management+L.P.+13F SEC" title="Search for Point72 Asset Management L.P.’s 11/14/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220816000000">8/16/2022</td>
              <td>Woodline Partners LP</td>
              <td>1,314,652</td>
              <td data-sort="6402000">$6.40M</td>
              <td>0.1%</td>
              <td class="c-green" data-sort="48.9%">+48.9%</td>
              <td>1.398%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Woodline+Partners+LP+13F SEC" title="Search for Woodline Partners LP’s 8/16/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220812000000">8/12/2022</td>
              <td>Ensign Peak Advisors Inc</td>
              <td>123,071</td>
              <td data-sort="599000">$0.60M</td>
              <td>0.0%</td>
              <td class="c-red" data-sort="-61.1%">-61.1%</td>
              <td>0.131%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Ensign+Peak+Advisors+Inc+13F SEC" title="Search for Ensign Peak Advisors Inc’s 8/12/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220812000000">8/12/2022</td>
              <td>Franklin Resources Inc.</td>
              <td>832,932</td>
              <td data-sort="4056000">$4.06M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="35.0%">+35.0%</td>
              <td>0.886%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Franklin+Resources+Inc.+13F SEC" title="Search for Franklin Resources Inc.’s 8/12/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220811000000">8/11/2022</td>
              <td>Alps Advisors Inc.</td>
              <td>55,785</td>
              <td data-sort="272000">$0.27M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.059%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Alps+Advisors+Inc.+13F SEC" title="Search for Alps Advisors Inc.’s 8/11/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220804000000">8/4/2022</td>
              <td>TD Asset Management Inc.</td>
              <td>82,055</td>
              <td data-sort="400000">$0.40M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="146.8%">+146.8%</td>
              <td>0.087%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=TD+Asset+Management+Inc.+13F SEC" title="Search for TD Asset Management Inc.’s 8/4/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220726000000">7/26/2022</td>
              <td>Mirae Asset Global Investments Co. Ltd.</td>
              <td>57,342</td>
              <td data-sort="703000">$0.70M</td>
              <td>0.0%</td>
              <td data-sort="0">N/A</td>
              <td>0.061%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Mirae+Asset+Global+Investments+Co.+Ltd.+13F SEC" title="Search for Mirae Asset Global Investments Co. Ltd.’s 7/26/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220513000000">5/13/2022</td>
              <td>Kynam Capital Management LP</td>
              <td>669,100</td>
              <td data-sort="6002000">$6M</td>
              <td>1.9%</td>
              <td class="c-green" data-sort="179.9%">+179.9%</td>
              <td>0.712%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Kynam+Capital+Management+LP+13F SEC" title="Search for Kynam Capital Management LP’s 5/13/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220504000000">5/4/2022</td>
              <td>OUP Management Co. LLC</td>
              <td>2,937,615</td>
              <td data-sort="26350000">$26.35M</td>
              <td>20.1%</td>
              <td class="c-green" data-sort="25.4%">+25.4%</td>
              <td>3.124%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=OUP+Management+Co.+LLC+13F SEC" title="Search for OUP Management Co. LLC’s 5/4/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220219000000">2/19/2022</td>
              <td>Woodline Partners LP</td>
              <td>801,136</td>
              <td data-sort="9021000">$9.02M</td>
              <td>0.1%</td>
              <td class="c-red" data-sort="-9.3%">-9.3%</td>
              <td>0.891%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Woodline+Partners+LP+13F SEC" title="Search for Woodline Partners LP’s 2/19/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220215000000">2/15/2022</td>
              <td>Samsara BioCapital LLC</td>
              <td>1,459,693</td>
              <td data-sort="16436000">$16.44M</td>
              <td>3.2%</td>
              <td class="c-red" data-sort="-5.1%">-5.1%</td>
              <td>1.624%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Samsara+BioCapital+LLC+13F SEC" title="Search for Samsara BioCapital LLC’s 2/15/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220214000000">2/14/2022</td>
              <td>Virtus ETF Advisers LLC</td>
              <td>14,798</td>
              <td data-sort="167000">$0.17M</td>
              <td>0.1%</td>
              <td data-sort="0">N/A</td>
              <td>0.016%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Virtus+ETF+Advisers+LLC+13F SEC" title="Search for Virtus ETF Advisers LLC’s 2/14/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="even">
              <td data-sort="20220214000000">2/14/2022</td>
              <td>Boxer Capital LLC</td>
              <td>1,251,137</td>
              <td data-sort="14088000">$14.09M</td>
              <td>0.5%</td>
              <td class="c-red" data-sort="-6.2%">-6.2%</td>
              <td>1.392%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Boxer+Capital+LLC+13F SEC" title="Search for Boxer Capital LLC’s 2/14/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
            <tr class="odd">
              <td data-sort="20220214000000">2/14/2022</td>
              <td>Point72 Asset Management L.P.</td>
              <td>1,097,908</td>
              <td data-sort="12362000">$12.36M</td>
              <td>0.0%</td>
              <td class="c-green" data-sort="263.3%">+263.3%</td>
              <td>1.221%</td>
              <td style="min-width:75px;text-align:center;">
                <a rel="nofollow noopener" href="https://www.google.com/search?q=Point72+Asset+Management+L.P.+13F SEC" title="Search for Point72 Asset Management L.P.’s 2/14/2022 SEC report of Centessa Pharmaceuticals shares on Google" target="_blank"><img src="/images/insider-trades-icon-search.svg?v=2" width="27" height="27" alt="Search for SEC Filing on Google Icon" loading="lazy"></a>
              </td>
            </tr>
          </tbody>
        </table><em>Data available starting January 2016</em><br><br>
      </div>
      <div class="see-more-fade d-none">
        <div class="container see-more-fade-inner">
          <div class="c-blue see-more-button button">See Full Table</div>
        </div>
      </div>
    </div>
    <div class="bg-gray mt-1">
      <div class="container" id="about">
        <div id="company-description" class="d-sm-flex my-2">
          <div style="flex: 0 1 250px; -ms-flex: 0 1 250px;text-align:center;">
            <div class="bg-white p-1"><img style="max-height: 100px;width:auto;" src="https://www.insidertrades.com/logos/centessa-pharmaceuticals-plc-logo.png?v=20221214073029" title="Centessa Pharmaceuticals logo"
                alt="Centessa Pharmaceuticals logo" height="71" width="500" loading="lazy"></div>
          </div>
          <div style="padding:.25rem 1rem;flex:1;-ms-flex:1;">
            <div class="read-more-section clickable" data-heightcutoff="140"> Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an
              activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a
              bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the
              treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical
              assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.</div>
            <div class="a-dark-green read-more-button">Read More <span class="sr-only"> on Centessa Pharmaceuticals</span></div>
          </div>
        </div>
      </div>
    </div>
    <div class="container">
      <div class="super-border-bottom">
        <div class="row d-md-flex pb-1">
          <div class="w-33 p-1">
            <h4>Today's Range</h4>
            <strong>Now: $16.90</strong>
            <div style="overflow:hidden">
              <div class="range-mini-chart"><span class="sr-only">Low: </span>$16.46<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:33.33%"></span></div><span class="sr-only">High: </span>$17.78</div>
            </div>
          </div>
          <div class="w-33 p-1">
            <h4>50 Day Range</h4>
            <strong>MA: $16.66</strong>
            <div style="overflow:hidden">
              <div class="range-mini-chart"><span class="sr-only">Low: </span>$15.04<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:44.63%"></span></div><span class="sr-only">High: </span>$18.67</div>
            </div>
          </div>
          <div class="w-33 p-1">
            <h4>52 Week Range</h4>
            <strong>Now: $16.90</strong>
            <div style="overflow:hidden">
              <div class="range-mini-chart"><span class="sr-only">Low: </span>$6.65<div class="range"><span class="range-quadrants"></span><span class="range-marker" style="left:83.20%"></span></div><span class="sr-only">High: </span>$18.97</div>
            </div>
          </div>
        </div>
      </div>
      <div class="super-border-bottom">
        <div class="row d-sm-flex pb-1">
          <div class="w-33 p-1">
            <h4>Volume</h4> 193,914 shs
          </div>
          <div class="w-33 p-1">
            <h4>Average Volume</h4> 433,210 shs
          </div>
          <div class="w-33 p-1">
            <h4>Market Capitalization</h4> $2.23 billion
          </div>
        </div>
      </div>
      <div class="super-border-bottom">
        <div class="row d-sm-flex pb-1">
          <div class="w-33 p-1">
            <h4>P/E Ratio</h4> N/A
          </div>
          <div class="w-33 p-1">
            <h4>Dividend Yield</h4> N/A
          </div>
          <div class="w-33 p-1">
            <h4>Beta</h4> 1.52
          </div>
        </div>
      </div>
    </div>
    <div class="container" id="insider-trading-faq">
      <dl class="body-copy my-2 row d-md-flex flex-wrap" itemscope="" itemtype="https://schema.org/FAQPage">
        <div class="w-50 col" itemscope="" itemprop="mainEntity" itemtype="https://schema.org/Question">
          <dt>
            <h4 id="question1" class="question h3 mt-0 c-dark-blue m-0 border-left b-dark-blue pl-5" itemprop="name text">Who are the company insiders with the largest holdings of Centessa Pharmaceuticals?</h4>
          </dt>
          <dd>
            <div itemprop="acceptedAnswer" itemscope="" itemtype="https://schema.org/Answer" class="answer pl-5 pt-3">
              <div itemprop="text" id="answer1">Centessa Pharmaceuticals' top insider shareholders include:<ol>
                  <li>Saurabh Saha (CEO)</li>
                  <li>Antoine Yver (EVP)</li>
                  <li>Gregory M Weinhoff (Insider)</li>
                  <li>Tia L Bush (Insider)</li>
                  <li>Tia L Bush (CTO)</li>
                  <li>Iqbal J Hussain (General Counsel)</li>
                  <li>Karen M Anderson (Insider)</li>
                  <li>Harris Rotman (SVP)</li>
                </ol><a class="sr-only sr-only-focusable" href="https://www.insidertrades.com/centessa-pharmaceuticals-plc-american-depositary-shares-stock/">Learn More about top insider investors at Centessa Pharmaceuticals.</a></div>
            </div>
          </dd>
        </div>
        <div class="w-50 col" itemscope="" itemprop="mainEntity" itemtype="https://schema.org/Question">
          <dt>
            <h4 id="question2" class="question h3 mt-0 c-dark-blue m-0 border-left b-dark-blue pl-5" itemprop="name text">Who are the major institutional investors of Centessa Pharmaceuticals?</h4>
          </dt>
          <dd>
            <div itemprop="acceptedAnswer" itemscope="" itemtype="https://schema.org/Answer" class="answer pl-5 pt-3">
              <div itemprop="text" id="answer2">Centessa Pharmaceuticals' top institutional investors include:<ol>
                  <li>FMR LLC — 2.57% </li>
                  <li>Point72 Asset Management L.P. — 2.40% </li>
                  <li>Franklin Resources Inc. — 1.75% </li>
                  <li>Janus Henderson Group PLC — 1.14% </li>
                  <li>Baker BROS. Advisors LP — 1.08% </li>
                  <li>Ally Bridge Group NY LLC — 0.27% </li>
                </ol><a class="sr-only sr-only-focusable" href="https://www.insidertrades.com/centessa-pharmaceuticals-plc-american-depositary-shares-stock/">Learn More about top institutional investors of Centessa Pharmaceuticals stock.</a></div>
            </div>
          </dd>
        </div>
        <div class="w-50 col" itemscope="" itemprop="mainEntity" itemtype="https://schema.org/Question">
          <dt>
            <h4 id="question3" class="question h3 mt-0 c-dark-blue m-0 border-left b-dark-blue pl-5" itemprop="name text">Which institutional investors are selling Centessa Pharmaceuticals stock?</h4>
          </dt>
          <dd>
            <div itemprop="acceptedAnswer" itemscope="" itemtype="https://schema.org/Answer" class="answer pl-5 pt-3">
              <div itemprop="text" id="answer3">Within the previous quarter, CNTA stock was sold by these institutional investors: <ol>
                  <li>PFM Health Sciences LP </li>
                  <li>Exome Asset Management LLC </li>
                  <li>XTX Topco Ltd </li>
                </ol>During the previous year, company insiders that have sold Centessa Pharmaceuticals company stock include: <ol>
                  <li>Saurabh Saha (CEO)</li>
                  <li>Antoine Yver (EVP)</li>
                  <li>Gregory M Weinhoff (Insider)</li>
                  <li>Tia L Bush (Insider)</li>
                  <li>Tia L Bush (CTO)</li>
                  <li>Iqbal J Hussain (General Counsel)</li>
                </ol><a class="sr-only sr-only-focusable" href="https://www.insidertrades.com/centessa-pharmaceuticals-plc-american-depositary-shares-stock/">Learn More investors selling Centessa Pharmaceuticals stock.</a></div>
            </div>
          </dd>
        </div>
        <div class="w-50 col" itemscope="" itemprop="mainEntity" itemtype="https://schema.org/Question">
          <dt>
            <h4 id="question4" class="question h3 mt-0 c-dark-blue m-0 border-left b-dark-blue pl-5" itemprop="name text">Which institutional investors are buying Centessa Pharmaceuticals stock?</h4>
          </dt>
          <dd>
            <div itemprop="acceptedAnswer" itemscope="" itemtype="https://schema.org/Answer" class="answer pl-5 pt-3">
              <div itemprop="text" id="answer4">Within the previous quarter, CNTA stock was purchased by institutional investors including: <ol>
                  <li>Janus Henderson Group PLC </li>
                  <li>Franklin Resources Inc. </li>
                  <li>Point72 Asset Management L.P. </li>
                  <li>Baker BROS. Advisors LP </li>
                  <li>Ally Bridge Group NY LLC </li>
                  <li>Lord Abbett &amp; CO. LLC </li>
                  <li>Jane Street Group LLC </li>
                  <li>Fred Alger Management LLC </li>
                </ol>
              </div>
            </div>
          </dd>
        </div>
      </dl>
    </div>
    <script>
      var chartPrefix = 'NASDAQ';
      var chartSymbol = 'CNTA';
      var priceSeriesCurrencySymbol = "$";
      var InsiderTradesSeries =
        "ActualDate,Date,AmountBought,AmountSold,Currency\n10/01/2021,11/15/2021,2891263,0,$\n01/01/2022,02/15/2022,297575,0,$\n04/01/2022,05/15/2022,46300,152659,$\n07/01/2022,08/15/2022,0,253035,$\n10/01/2022,11/15/2022,0,188479,$\n01/01/2023,02/15/2023,0,22165,$\n04/01/2023,05/15/2023,0,94821,$\n07/01/2023,08/15/2023,0,235774,$\n10/01/2023,11/15/2023,0,0,$\n01/01/2024,02/15/2024,0,642344,$\n04/01/2024,05/15/2024,0,0,$\n07/01/2024,08/15/2024,0,4641902,$\n10/01/2024,11/15/2024,0,6165174,$";
      var SECFilingSeries =
        "ActualDate,Date,AmountBought,AmountSold,Currency\n10/01/2021,11/15/2021,190263106.8,7944994.2,$\n01/01/2022,02/15/2022,70559984.3,4100058.3,$\n04/01/2022,05/15/2022,17335732.7,0,$\n07/01/2022,08/15/2022,13688628.2,3270657,$\n10/01/2022,11/15/2022,51869294.1,16843756.8,$\n01/01/2023,02/15/2023,65475839,0,$\n04/01/2023,05/15/2023,58930942.2,19288375.6,$\n07/01/2023,08/15/2023,6560934.9,692274.7,$\n10/01/2023,11/15/2023,22377053.4,0,$\n01/01/2024,02/15/2024,32975263.1,14172576.6,$\n04/01/2024,05/15/2024,74215268.4,0,$\n07/01/2024,08/15/2024,105921679.5,10824500.7,$\n10/01/2024,11/15/2024,95698142.8,8609603.6,$";
      var priceSeries =
        "Date,SharePrice\n01/01/2024,7.96\n01/02/2024,8.03\n01/03/2024,7.82\n01/04/2024,7.29\n01/05/2024,6.73\n01/06/2024,6.73\n01/07/2024,6.73\n01/08/2024,7.1\n01/09/2024,7.3\n01/10/2024,6.97\n01/11/2024,6.91\n01/12/2024,7.1\n01/13/2024,7.1\n01/14/2024,7.1\n01/15/2024,7.1\n01/16/2024,7.3\n01/17/2024,7.96\n01/18/2024,7.63\n01/19/2024,8.1\n01/20/2024,8.1\n01/21/2024,8.1\n01/22/2024,8.14\n01/23/2024,8.04\n01/24/2024,8\n01/25/2024,7.83\n01/26/2024,8.11\n01/27/2024,8.11\n01/28/2024,8.11\n01/29/2024,8.78\n01/30/2024,8.27\n01/31/2024,8.19\n02/01/2024,8.01\n02/02/2024,7.87\n02/03/2024,7.87\n02/04/2024,7.87\n02/05/2024,8.15\n02/06/2024,8.12\n02/07/2024,7.57\n02/08/2024,7.46\n02/09/2024,9.26\n02/10/2024,9.26\n02/11/2024,9.26\n02/12/2024,9.6\n02/13/2024,9.5\n02/14/2024,10.18\n02/15/2024,10.83\n02/16/2024,11.75\n02/17/2024,11.75\n02/18/2024,11.75\n02/19/2024,11.75\n02/20/2024,10.66\n02/21/2024,10.4\n02/22/2024,10.75\n02/23/2024,11.01\n02/24/2024,11.01\n02/25/2024,11.01\n02/26/2024,11.29\n02/27/2024,11.36\n02/28/2024,10.44\n02/29/2024,10.51\n03/01/2024,10.87\n03/02/2024,10.87\n03/03/2024,10.87\n03/04/2024,11.17\n03/05/2024,10.89\n03/06/2024,11.03\n03/07/2024,11.06\n03/08/2024,11.03\n03/09/2024,11.03\n03/10/2024,11.03\n03/11/2024,9.75\n03/12/2024,10.86\n03/13/2024,10.85\n03/14/2024,10.47\n03/15/2024,10.75\n03/16/2024,10.75\n03/17/2024,10.75\n03/18/2024,10.62\n03/19/2024,11.17\n03/20/2024,11.84\n03/21/2024,12.08\n03/22/2024,12.2\n03/23/2024,12.2\n03/24/2024,12.2\n03/25/2024,11.51\n03/26/2024,10.76\n03/27/2024,11.1\n03/28/2024,11.3\n03/29/2024,11.3\n03/30/2024,11.3\n03/31/2024,11.3\n04/01/2024,11.08\n04/02/2024,11.33\n04/03/2024,10.82\n04/04/2024,10.37\n04/05/2024,10.75\n04/06/2024,10.75\n04/07/2024,10.75\n04/08/2024,10.75\n04/09/2024,11.305\n04/10/2024,11.15\n04/11/2024,11.87\n04/12/2024,11.32\n04/13/2024,11.32\n04/14/2024,11.32\n04/15/2024,10.78\n04/16/2024,11.03\n04/17/2024,10.78\n04/18/2024,10.53\n04/19/2024,10.57\n04/20/2024,10.57\n04/21/2024,10.57\n04/22/2024,10\n04/23/2024,9.4\n04/24/2024,9.46\n04/25/2024,8.93\n04/26/2024,8.92\n04/27/2024,8.92\n04/28/2024,8.92\n04/29/2024,9.29\n04/30/2024,9.16\n05/01/2024,9.48\n05/02/2024,9.55\n05/03/2024,9.47\n05/04/2024,9.47\n05/05/2024,9.47\n05/06/2024,9.25\n05/07/2024,9.67\n05/08/2024,9.48\n05/09/2024,9.55\n05/10/2024,8.97\n05/11/2024,8.97\n05/12/2024,8.97\n05/13/2024,8.83\n05/14/2024,9.04\n05/15/2024,8.79\n05/16/2024,8.95\n05/17/2024,8.87\n05/18/2024,8.87\n05/19/2024,8.87\n05/20/2024,8.72\n05/21/2024,8.6\n05/22/2024,8.75\n05/23/2024,8.35\n05/24/2024,8.27\n05/25/2024,8.27\n05/26/2024,8.27\n05/27/2024,8.27\n05/28/2024,8.1\n05/29/2024,8.04\n05/30/2024,8.12\n05/31/2024,8.63\n06/01/2024,8.63\n06/02/2024,8.63\n06/03/2024,8.5\n06/04/2024,8.44\n06/05/2024,8.8\n06/06/2024,8.92\n06/07/2024,8.8\n06/08/2024,8.8\n06/09/2024,8.8\n06/10/2024,9.08\n06/11/2024,9.33\n06/12/2024,9.7\n06/13/2024,9.93\n06/14/2024,10.18\n06/15/2024,10.18\n06/16/2024,10.18\n06/17/2024,9.53\n06/18/2024,8.515\n06/19/2024,8.515\n06/20/2024,8.86\n06/21/2024,9.1\n06/22/2024,9.1\n06/23/2024,9.1\n06/24/2024,8.89\n06/25/2024,8.89\n06/26/2024,8.99\n06/27/2024,8.98\n06/28/2024,9.03\n06/29/2024,9.03\n06/30/2024,9.03\n07/01/2024,8.8\n07/02/2024,8.77\n07/03/2024,8.58\n07/04/2024,8.58\n07/05/2024,8.74\n07/06/2024,8.74\n07/07/2024,8.74\n07/08/2024,9.02\n07/09/2024,9.79\n07/10/2024,9.9\n07/11/2024,9.57\n07/12/2024,9.86\n07/13/2024,9.86\n07/14/2024,9.86\n07/15/2024,9.54\n07/16/2024,9.93\n07/17/2024,9.52\n07/18/2024,9.53\n07/19/2024,9.43\n07/20/2024,9.43\n07/21/2024,9.43\n07/22/2024,9.4\n07/23/2024,9.87\n07/24/2024,10.24\n07/25/2024,10.29\n07/26/2024,10.78\n07/27/2024,10.78\n07/28/2024,10.78\n07/29/2024,10.65\n07/30/2024,10.61\n07/31/2024,10.53\n08/01/2024,10.29\n08/02/2024,10.07\n08/03/2024,10.07\n08/04/2024,10.07\n08/05/2024,10.28\n08/06/2024,10.75\n08/07/2024,10.91\n08/08/2024,11.4\n08/09/2024,11.04\n08/10/2024,11.04\n08/11/2024,11.04\n08/12/2024,10.55\n08/13/2024,11.01\n08/14/2024,12.6\n08/15/2024,13.09\n08/16/2024,12.5\n08/17/2024,12.5\n08/18/2024,12.5\n08/19/2024,12.31\n08/20/2024,12.02\n08/21/2024,12.21\n08/22/2024,12.2\n08/23/2024,12.85\n08/24/2024,12.85\n08/25/2024,12.85\n08/26/2024,13.92\n08/27/2024,13.5\n08/28/2024,13.48\n08/29/2024,13.04\n08/30/2024,13.5\n08/31/2024,13.5\n09/01/2024,13.5\n09/02/2024,13.5\n09/03/2024,13.5\n09/04/2024,14.63\n09/05/2024,14.6\n09/06/2024,14.3\n09/07/2024,14.3\n09/08/2024,14.3\n09/09/2024,14.93\n09/10/2024,14.58\n09/11/2024,13.75\n09/12/2024,15.1\n09/13/2024,16.99\n09/14/2024,16.99\n09/15/2024,16.99\n09/16/2024,16.46\n09/17/2024,16.28\n09/18/2024,15.71\n09/19/2024,15.85\n09/20/2024,16.58\n09/21/2024,16.58\n09/22/2024,16.58\n09/23/2024,15.57\n09/24/2024,15.52\n09/25/2024,15.34\n09/26/2024,15.67\n09/27/2024,15.79\n09/28/2024,15.79\n09/29/2024,15.79\n09/30/2024,15.99\n10/01/2024,17.2\n10/02/2024,16.26\n10/03/2024,15.88\n10/04/2024,15.94\n10/05/2024,15.94\n10/06/2024,15.94\n10/07/2024,15.51\n10/08/2024,16.08\n10/09/2024,15.54\n10/10/2024,15.66\n10/11/2024,15.99\n10/12/2024,15.99\n10/13/2024,15.99\n10/14/2024,16.66\n10/15/2024,16.09\n10/16/2024,16.29\n10/17/2024,15.81\n10/18/2024,16.05\n10/19/2024,16.05\n10/20/2024,16.05\n10/21/2024,15.79\n10/22/2024,15.46\n10/23/2024,15.15\n10/24/2024,15.5\n10/25/2024,15.5\n10/26/2024,15.5\n10/27/2024,15.5\n10/28/2024,15.51\n10/29/2024,15.44\n10/30/2024,15.09\n10/31/2024,15.04\n11/01/2024,15.67\n11/02/2024,15.67\n11/03/2024,15.67\n11/04/2024,15.89\n11/05/2024,16\n11/06/2024,15.99\n11/07/2024,16.14\n11/08/2024,16.5\n11/09/2024,16.5\n11/10/2024,16.5\n11/11/2024,16.73\n11/12/2024,17\n11/13/2024,18.08\n11/14/2024,17.5\n11/15/2024,16\n11/16/2024,16\n11/17/2024,16\n11/18/2024,16.1\n11/19/2024,16.83\n11/20/2024,16.74\n11/21/2024,18.19\n11/22/2024,17.04\n11/23/2024,17.04\n11/24/2024,17.04\n11/25/2024,17.1\n11/26/2024,17.3\n11/27/2024,17.6\n11/28/2024,17.6\n11/29/2024,17.91\n11/30/2024,17.91\n12/01/2024,17.91\n12/02/2024,16.95\n12/03/2024,17.12\n12/04/2024,17.16\n12/05/2024,17.49\n12/06/2024,18.67\n12/07/2024,18.67\n12/08/2024,18.67\n12/09/2024,18.06\n12/10/2024,17.04\n12/11/2024,17.18\n12/12/2024,16.87\n12/13/2024,16.57\n12/14/2024,16.57\n12/15/2024,16.57\n12/16/2024,16.75\n12/17/2024,17.6\n12/18/2024,16.51\n12/19/2024,17.55\n12/20/2024,17.16\n12/21/2024,17.16\n12/22/2024,17.16\n12/23/2024,17.53\n12/24/2023,8\n12/24/2024,16.9\n12/25/2023,8\n12/26/2023,7.95\n12/27/2023,7.99\n12/28/2023,8.03\n12/29/2023,7.96\n12/30/2023,7.96\n12/31/2023,7.96";
    </script>
  </div>
</form>

Text Content

Skip to main content
 * Insiders
 * Latest Transactions
   * All Transactions
   * Insider Buying
   * Insider Selling
 * Companies
   * Consumer Discretionary
   * Finance
   * Computer and Technology
   * Oils/Energy
   * Business Services
   * Medical
   * Retail/Wholesale
   * Aerospace
   * Basic Materials
   * Utilities
 * Education
   * About Insider Trading
   * Articles
   * News Alerts
 * Tools
   * All Tools
   * CEO Buys
   * CFO Buys
   * COO Buys
   * Double Buys
   * Triple Buys
   * Most Bought Stocks
   * Most Sold Stocks
 * Account
   * Log In
   * Contact

Wall St. Icon: “If you wait on this, it will already be too late”
From InvestorPlace   |   Ad
If you have a significant amount of money in the stock market right now — or if
you're sitting on the sidelines waiting to make a move — you DO NOT want to miss
my latest research.
Go here now to see my urgent warning


CNTA INSIDER TRADING

 * Insider Trading Chart
 * Insider Trading History
 * Frequently Asked Questions
 * About

Insider Ownership Percentage: 11.59%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $11,449,419.49


CENTESSA PHARMACEUTICALS INSIDER TRADING HISTORY CHART

This chart shows the insider buying and selling history at Centessa
Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table



CENTESSA PHARMACEUTICALS SHARE PRICE & PRICE HISTORY

Current Price: $16.90
Price Change: ▼ Price Decrease of -0.63 (-3.59%)
As of 12/24/2024 03:33 PM ET

This chart shows the closing price history over time for CNTA up to the past
year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he
believes will be worth more than $9 trillion. That’s nearly 10 times more money
than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.


CENTESSA PHARMACEUTICALS INSIDER TRADING HISTORY

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share
PriceTotal TransactionShares Held After TransactionDetails12/20/2024Saurabh
SahaCEOSell55,000$17.44$959,200.00520,661  12/17/2024Karen M
AndersonInsiderSell10,624$17.32$184,007.6871,525  12/17/2024Tia L.
BushCTOSell17,813$18.00$320,634.00147,615  12/16/2024Iqbal J HussainGeneral
CounselSell77,705$16.39$1,273,584.95125,785  12/13/2024Karen M
AndersonInsiderSell5,876$17.01$99,950.7671,525  12/6/2024Saurabh
SahaCEOSell87,496$18.46$1,615,176.16575,661  11/25/2024Gregory M
WeinhoffInsiderSell10,000$17.66$176,600.00183,266  11/25/2024Saurabh
SahaCEOSell299$18.23$5,450.77575,661  11/22/2024Saurabh
SahaCEOSell1,671$18.24$30,479.04575,661  11/20/2024Saurabh
SahaCEOSell55,000$16.89$928,950.00575,661  10/25/2024Gregory M
WeinhoffInsiderSell11,742$15.38$180,591.96183,266  10/23/2024Saurabh
SahaCEOSell2,592$15.32$39,709.44630,661  10/21/2024Saurabh
SahaCEOSell22,205$15.80$350,839.00663,456  9/25/2024Gregory M
WeinhoffInsiderSell16,619$15.69$260,752.11206,750  9/20/2024Saurabh
SahaCEOSell55,000$16.53$909,150.00721,924  9/10/2024Saurabh
SahaCEOSell175,000$16.52$2,891,000.00776,924  9/9/2024Gregory M
WeinhoffInsiderSell25,000$15.00$375,000.00223,369  8/22/2024Gregory M
WeinhoffInsiderSell12,198$12.17$148,449.66241,171  8/22/2024Saurabh
SahaCEOSell506$12.23$6,188.38823,575  8/20/2024Saurabh
SahaCEOSell4,169$12.32$51,362.08827,755  3/25/2024Karen M
AndersonInsiderSell51,160$11.88$607,780.8071,525  2/1/2024Harris
RotmanSVPSell4,267$8.10$34,562.7062,625  9/20/2023Harris
RotmanSVPSell37,484$6.29$235,774.3633,500  6/1/2023Antoine
YverEVPSell6,500$4.45$28,925.00783,066  5/24/2023Tia L.
BushInsiderSell8,000$4.48$35,840.00157,102  5/1/2023Antoine
YverEVPSell6,800$4.42$30,056.00789,566  1/4/2023Antoine
YverEVPSell6,970$3.18$22,164.60751,913  12/1/2022Antoine
YverEVPSell9,400$3.91$36,754.00761,151  11/1/2022Antoine
YverEVPSell9,700$4.03$39,091.00765,059  10/3/2022Antoine
YverEVPSell12,524$3.92$49,094.08774,759  10/3/2022David M
ChaoInsiderSell4,167$3.95$16,459.65222,932  10/3/2022Gregory M
WeinhoffCFOSell4,901$3.95$19,358.95231,099  10/3/2022Iqbal J HussainGeneral
CounselSell4,563$3.95$18,023.85154,712  10/3/2022Thomas
TemplemanCTOSell2,455$3.95$9,697.25135,792  9/30/2022Antoine
YverEVPSell2,468$4.07$10,044.76787,283  9/30/2022David M
ChaoInsiderSell3,401$4.07$13,842.07227,099  9/30/2022Gregory M
WeinhoffCFOSell4,000$4.07$16,280.00236,000  9/30/2022Iqbal J HussainGeneral
CounselSell3,725$4.07$15,160.75159,275  9/30/2022Thomas
TemplemanCTOSell2,003$4.07$8,152.21138,247  8/1/2022Antoine
YverEVPSell10,423$4.45$46,382.35800,174  7/18/2022Antoine
YverEVPSell20,000$4.87$97,400.00810,597  7/1/2022Antoine
YverEVPSell9,100$5.03$45,773.00730,597  6/24/2022Saurabh
SahaCEOBuy10,000$4.63$46,300.0038,000  6/17/2022Antoine
YverEVPSell9,200$4.68$43,056.00739,697  5/17/2022Antoine
YverEVPSell20,222$5.42$109,603.24813,675  2/2/2022Saurabh
SahaCEOBuy5,000$9.74$48,700.00  1/28/2022David J.
GraingerInsiderBuy27,500$9.05$248,875.00  

See Full Table
Wall St. Icon: “If you wait on this, it will already be too late”
From InvestorPlace   |   Ad
If you have a significant amount of money in the stock market right now — or if
you're sitting on the sidelines waiting to make a move — you DO NOT want to miss
my latest research.
Go here now to see my urgent warning


SEC FILINGS (INSTITUTIONAL OWNERSHIP CHANGES) FOR CENTESSA PHARMACEUTICALS
(NASDAQ:CNTA)

82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional
ownership can be a sign of analyst confidence in the fundamentals of the stock.


INSTITUTIONAL BUYING AND SELLING BY QUARTER

This chart shows the instiutional buying and selling at CNTA by year and by
quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in
Institutional Trading History Table



CENTESSA PHARMACEUTICALS INSTITUTIONAL TRADING HISTORY

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in
SharesOwnership in CompanyDetails12/13/2024Lord Abbett & CO.
LLC269,205$4.31M0.0%N/A0.204%12/13/2024Exome Asset Management
LLC138,152$2.21M1.5%-49.7%0.105%11/27/2024Franklin Resources
Inc.2,302,546$38.36M0.0%+99.1%1.746%11/16/2024Geode Capital Management
LLC56,597$0.91M0.0%+68.7%0.050%11/15/2024XTX Topco
Ltd10,174$0.16M0.0%-37.9%0.009%11/15/2024Jane Street Group
LLC177,260$2.83M0.0%N/A0.156%11/15/2024Wellington Management Group
LLP100,613$1.61M0.0%N/A0.089%11/15/2024State Street
Corp48,592$0.78M0.0%N/A0.043%11/15/2024RTW Investments
LP50,000$0.80M0.0%N/A0.044%11/15/2024Point72 Asset Management
L.P.2,715,663$43.42M0.1%+54.1%2.397%11/15/2024Janus Henderson Group
PLC1,294,864$20.70M0.0%N/A1.143%11/15/2024HighVista Strategies
LLC46,116$0.74M0.3%N/A0.041%11/15/2024Baker BROS. Advisors
LP1,227,178$19.62M0.2%+123.4%1.083%11/14/2024PFM Health Sciences
LP269,158$4.30M0.2%-57.7%0.238%11/14/2024Fred Alger Management
LLC177,553$2.84M0.0%+1,515.1%0.157%11/14/2024Walleye Capital
LLC11,721$0.19M0.0%N/A0.010%11/14/2024Suvretta Capital Management
LLC70,000$1.12M0.0%N/A0.062%11/14/2024Ally Bridge Group NY
LLC309,614$4.95M2.7%N/A0.273%11/13/2024FMR
LLC2,916,494$46.64M0.0%+4.6%2.574%11/13/2024The Manufacturers Life Insurance
Company264,969$4.24M0.0%+88.1%0.234%11/5/2024GSA Capital Partners
LLP93,658$1.50M0.1%+66.1%0.083%11/1/2024Atria Investments
Inc17,134$0.27M0.0%+7.0%0.015%10/25/2024China Universal Asset Management Co.
Ltd.13,593$0.22M0.0%+99.7%0.014%10/23/2024Mirae Asset Global Investments Co.
Ltd.2,556$40K0.0%+47.7%0.003%10/17/2024Harbour Capital Advisors
LLC16,675$0.26M0.1%N/A0.017%10/7/2024GAMMA Investing
LLC2,972$48K0.0%+103.1%0.003%9/16/2024Cubist Systematic Strategies
LLC26,073$0.24M0.0%-64.1%0.026%8/20/2024Nantahala Capital Management
LLC450,000$4.06M0.2%N/A0.448%8/19/2024Point72 Asset Management
L.P.1,762,004$15.91M0.0%-22.0%1.754%8/16/2024Perceptive Advisors
LLC3,933,307$35.52M0.8%+27.6%3.914%8/16/2024Quarry
LP9,608$87K0.0%+47.8%0.010%8/16/2024Driehaus Capital Management
LLC2,092,011$18.89M0.2%+89.5%2.082%8/15/2024The Manufacturers Life Insurance
Company140,894$1.27M0.0%+30.4%0.140%8/15/2024Affinity Asset Advisors
LLC1,135,702$10.26M1.2%+36.7%1.130%8/14/2024Fred Alger Management
LLC10,993$99K0.0%N/A0.011%8/14/2024Sandia Investment Management
LP10,000$90K0.1%N/A0.010%8/14/2024Cubist Systematic Strategies
LLC26,073$0.24M0.0%-64.1%0.026%8/14/2024First Light Asset Management
LLC4,780,560$43.17M3.8%+59.2%4.758%8/14/2024Marshall Wace
LLP224,948$2.03M0.0%-2.9%0.224%8/14/2024Farallon Capital Management
LLC1,996,000$18.02M0.1%+438.0%1.986%8/12/2024XTX Topco
Ltd16,385$0.15M0.0%N/A0.016%8/9/2024Renaissance Technologies
LLC173,700$1.57M0.0%-20.6%0.173%8/8/2024American Century Companies
Inc.935,151$8.44M0.0%+1.3%0.931%8/3/2024TD Asset Management
Inc321,168$2.90M0.0%+40.5%0.320%7/29/2024HighMark Wealth Management
LLC93,000$0.84M0.5%N/A0.093%5/30/2024Lynx1 Capital Management
LP17,400$0.20M0.1%N/A0.017%5/24/2024Farallon Capital Management
LLC371,000$4.19M0.0%N/A0.369%5/17/2024Artal Group
S.A.1,412,500$15.96M0.4%+39.5%1.250%5/15/2024First Light Asset Management
LLC3,002,045$33.92M2.6%N/A2.980%5/15/2024Price T Rowe Associates Inc.
MD2,958,079$33.43M0.0%+16.5%2.936%5/15/2024Affinity Asset Advisors
LLC830,546$9.39M1.2%+4.4%0.824%5/14/2024EntryPoint Capital
LLC9,636$0.11M0.1%N/A0.010%5/14/2024Platinum Investment Management
Ltd.485,174$5.48M0.2%+27.3%0.482%5/10/2024Acadian Asset Management
LLC29,409$0.33M0.0%N/A0.029%4/29/2024China Universal Asset Management Co.
Ltd.10,817$0.12M0.0%+69.2%0.011%2/20/2024Quarry
LP6,000$48K0.0%N/A0.006%2/15/2024Octagon Capital Advisors
LP2,060,100$16.40M2.6%+333.2%2.110%2/15/2024BVF Inc.
IL8,774,570$69.85M1.8%-3.6%8.988%2/14/2024Kynam Capital Management
LP442,704$3.52M0.4%-39.4%0.453%2/14/2024Platinum Investment Management
Ltd.381,083$3.03M0.1%+12.9%0.390%2/13/2024Affinity Asset Advisors
LLC795,729$6.33M1.2%-21.8%0.815%2/9/2024Franklin Resources
Inc.1,115,817$8.88M0.0%+34.1%1.143%2/9/2024Trexquant Investment
LP14,354$0.11M0.0%N/A0.015%2/7/2024Jump Financial
LLC14,300$0.11M0.0%N/A0.015%1/24/2024China Universal Asset Management Co.
Ltd.6,394$51K0.0%+371.2%0.007%11/15/2023Kynam Capital Management
LP730,472$4.73M0.8%+0.2%0.768%11/15/2023Acuta Capital Partners
LLC323,349$2.09M1.4%N/A0.340%11/15/2023Adage Capital Partners GP
L.L.C.2,830,500$18.31M0.0%+25.8%2.974%11/15/2023Affinity Asset Advisors
LLC1,018,091$6.59M1.9%+13.0%1.045%11/13/2023Rathbones Group
PLC31,300$0.20M0.0%N/A0.032%11/3/2023Platinum Investment Management
Ltd.337,544$2.18M0.1%+96.7%0.347%10/27/2023TD Asset Management
Inc186,310$1.21M0.0%+127.1%0.191%8/21/2023Affinity Asset Advisors
LLC900,723$5.58M1.9%+31.7%0.947%8/11/2023Platinum Investment Management
Ltd.171,625$1.06M0.0%N/A0.180%8/3/2023Tanager Wealth Management
LLP696,096$4.31M0.9%-5.6%0.728%5/16/2023BVF Inc.
IL9,423,215$36.28M1.3%+36.7%9.961%5/15/2023Affinity Asset Advisors
LLC684,127$2.63M0.9%+48.6%0.723%5/15/2023EcoR1 Capital
LLC5,618,779$21.63M0.7%+7.4%5.939%5/15/2023Sio Capital Management
LLC347,869$1.34M0.7%N/A0.368%4/18/2023Tanager Wealth Management
LLP737,059$2.84M0.7%-60.8%0.779%2/14/2023EcoR1 Capital
LLC5,232,279$16.22M0.5%+61.7%5.531%1/27/2023Tanager Wealth Management
LLP1,878,383$5.82M1.6%N/A1.986%11/15/2022Kynam Capital Management
LP731,521$2.94M0.6%-3.5%0.775%11/15/2022EcoR1 Capital
LLC3,236,352$13.01M0.4%+1,007.1%3.431%11/15/2022Ensign Peak Advisors
Inc248,228$1M0.0%+101.7%0.263%11/14/2022Cormorant Asset Management
LP1,972,728$7.93M0.6%-32.6%2.091%11/14/2022Point72 Asset Management
L.P.117,800$0.47M0.0%-11.8%0.125%8/16/2022Woodline Partners
LP1,314,652$6.40M0.1%+48.9%1.398%8/12/2022Ensign Peak Advisors
Inc123,071$0.60M0.0%-61.1%0.131%8/12/2022Franklin Resources
Inc.832,932$4.06M0.0%+35.0%0.886%8/11/2022Alps Advisors
Inc.55,785$0.27M0.0%N/A0.059%8/4/2022TD Asset Management
Inc.82,055$0.40M0.0%+146.8%0.087%7/26/2022Mirae Asset Global Investments Co.
Ltd.57,342$0.70M0.0%N/A0.061%5/13/2022Kynam Capital Management
LP669,100$6M1.9%+179.9%0.712%5/4/2022OUP Management Co.
LLC2,937,615$26.35M20.1%+25.4%3.124%2/19/2022Woodline Partners
LP801,136$9.02M0.1%-9.3%0.891%2/15/2022Samsara BioCapital
LLC1,459,693$16.44M3.2%-5.1%1.624%2/14/2022Virtus ETF Advisers
LLC14,798$0.17M0.1%N/A0.016%2/14/2022Boxer Capital
LLC1,251,137$14.09M0.5%-6.2%1.392%2/14/2022Point72 Asset Management
L.P.1,097,908$12.36M0.0%+263.3%1.221%

Data available starting January 2016


See Full Table
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company,
discovers, develops, and delivers medicines for patients. Its products pipeline
includes SerpinPC, an activated protein C inhibitor for the treatment of
hemophilia A and B; and ORX750, an orally administered OX2R agonist for the
treatment of narcolepsy and other sleep disorders. The company also develops
LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid
tumors, which is designed to selectively drive potent CD47 and CD3 effector
function activity while avoiding systemic toxicity; and OX2R Agonists compounds
are currently in development for the treatment of narcolepsy. In addition, its
products pipeline comprises ORX750, an orally administered selective orexin
receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep
disorders; and earlier-stage preclinical assets and discovery-stage programs.
Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in
Altrincham, the United Kingdom.
Read More on Centessa Pharmaceuticals

TODAY'S RANGE

Now: $16.90
Low: $16.46

High: $17.78

50 DAY RANGE

MA: $16.66
Low: $15.04

High: $18.67

52 WEEK RANGE

Now: $16.90
Low: $6.65

High: $18.97

VOLUME

193,914 shs

AVERAGE VOLUME

433,210 shs

MARKET CAPITALIZATION

$2.23 billion

P/E RATIO

N/A

DIVIDEND YIELD

N/A

BETA

1.52

WHO ARE THE COMPANY INSIDERS WITH THE LARGEST HOLDINGS OF CENTESSA
PHARMACEUTICALS?

Centessa Pharmaceuticals' top insider shareholders include:
 1. Saurabh Saha (CEO)
 2. Antoine Yver (EVP)
 3. Gregory M Weinhoff (Insider)
 4. Tia L Bush (Insider)
 5. Tia L Bush (CTO)
 6. Iqbal J Hussain (General Counsel)
 7. Karen M Anderson (Insider)
 8. Harris Rotman (SVP)

Learn More about top insider investors at Centessa Pharmaceuticals.

WHO ARE THE MAJOR INSTITUTIONAL INVESTORS OF CENTESSA PHARMACEUTICALS?

Centessa Pharmaceuticals' top institutional investors include:
 1. FMR LLC — 2.57%
 2. Point72 Asset Management L.P. — 2.40%
 3. Franklin Resources Inc. — 1.75%
 4. Janus Henderson Group PLC — 1.14%
 5. Baker BROS. Advisors LP — 1.08%
 6. Ally Bridge Group NY LLC — 0.27%

Learn More about top institutional investors of Centessa Pharmaceuticals stock.

WHICH INSTITUTIONAL INVESTORS ARE SELLING CENTESSA PHARMACEUTICALS STOCK?

Within the previous quarter, CNTA stock was sold by these institutional
investors:
 1. PFM Health Sciences LP
 2. Exome Asset Management LLC
 3. XTX Topco Ltd

During the previous year, company insiders that have sold Centessa
Pharmaceuticals company stock include:
 1. Saurabh Saha (CEO)
 2. Antoine Yver (EVP)
 3. Gregory M Weinhoff (Insider)
 4. Tia L Bush (Insider)
 5. Tia L Bush (CTO)
 6. Iqbal J Hussain (General Counsel)

Learn More investors selling Centessa Pharmaceuticals stock.

WHICH INSTITUTIONAL INVESTORS ARE BUYING CENTESSA PHARMACEUTICALS STOCK?

Within the previous quarter, CNTA stock was purchased by institutional investors
including:
 1. Janus Henderson Group PLC
 2. Franklin Resources Inc.
 3. Point72 Asset Management L.P.
 4. Baker BROS. Advisors LP
 5. Ally Bridge Group NY LLC
 6. Lord Abbett & CO. LLC
 7. Jane Street Group LLC
 8. Fred Alger Management LLC

Wall St. Icon: “If you wait on this, it will already be too late”
From InvestorPlace   |   Ad
If you have a significant amount of money in the stock market right now — or if
you're sitting on the sidelines waiting to make a move — you DO NOT want to miss
my latest research.
Go here now to see my urgent warning
About InsiderTrades.com | Contact
© MarketBeat Media, LLC dba InsiderTrades.com™ 2019-2024. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. InsiderTrades.com provides
comprehensive coverage of insider trading, including recent insider buying,
recent insider selling, and education about insider trading. InsiderTrades.com
does not provide financial advice and does not issue recommendations or offers
to buy stock or sell any security.

Our Accessibility Statement

© 2024 Market data provided is at least 10-minutes delayed and hosted by
Barchart Solutions. Information is provided 'as-is' and solely for informational
purposes, not for trading purposes or advice, and is delayed. To see all
exchange delays and terms of use please see disclaimer. Fundamental company data
provided by Zacks Investment Research. As a bonus to opt-ing into our email
newsletters, you will also get a free subscription to the Liberty Through Wealth
e-newsletter. You can opt out at any time.



Welcome to InsiderTrades.com


INSIDERTRADES.COM ASKS FOR YOUR CONSENT TO USE YOUR PERSONAL DATA TO:

 * 
   Personalised advertising and content, advertising and content measurement,
   audience research and services development
 * 
   Store and/or access information on a device


Learn more
 * 
   How can I change my choice?
 * 
   What if I don't consent?
 * 
   How does legitimate interest work?
 * 
   Do I have to consent to everything?

Your personal data will be processed and information from your device (cookies,
unique identifiers, and other device data) may be stored by, accessed by and
shared with 134 TCF vendor(s) and 64 ad partner(s), or used specifically by this
site or app.

Some vendors may process your personal data on the basis of legitimate interest,
which you can object to by managing your options below. Look for a link at the
bottom of this page to manage or withdraw consent in privacy and cookie
settings.

Consent



Manage options



Data preferences





MANAGE YOUR DATA

You can choose how your personal data is used. Vendors want your permission to
do the following:

TCF vendors


STORE AND/OR ACCESS INFORMATION ON A DEVICE

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

View details
Consent (119 vendors)


USE LIMITED DATA TO SELECT ADVERTISING

Advertising presented to you on this service can be based on limited data, such
as the website or app you are using, your non-precise location, your device type
or which content you are (or have been) interacting with (for example, to limit
the number of times an ad is presented to you).

View details
Consent (70 vendors)Legitimate interest (32 vendors)


CREATE PROFILES FOR PERSONALISED ADVERTISING

Information about your activity on this service (such as forms you submit,
content you look at) can be stored and combined with other information about you
(for example, information from your previous activity on this service and other
websites or apps) or similar users. This is then used to build or improve a
profile about you (that might include possible interests and personal aspects).
Your profile can be used (also later) to present advertising that appears more
relevant based on your possible interests by this and other entities.

View details
Consent (96 vendors)


USE PROFILES TO SELECT PERSONALISED ADVERTISING

Advertising presented to you on this service can be based on your advertising
profiles, which can reflect your activity on this service or other websites or
apps (like the forms you submit, content you look at), possible interests and
personal aspects.

View details
Consent (91 vendors)


CREATE PROFILES TO PERSONALISE CONTENT

Information about your activity on this service (for instance, forms you submit,
non-advertising content you look at) can be stored and combined with other
information about you (such as your previous activity on this service or other
websites or apps) or similar users. This is then used to build or improve a
profile about you (which might for example include possible interests and
personal aspects). Your profile can be used (also later) to present content that
appears more relevant based on your possible interests, such as by adapting the
order in which content is shown to you, so that it is even easier for you to
find content that matches your interests.

View details
Consent (28 vendors)


USE PROFILES TO SELECT PERSONALISED CONTENT

Content presented to you on this service can be based on your content
personalisation profiles, which can reflect your activity on this or other
services (for instance, the forms you submit, content you look at), possible
interests and personal aspects. This can for example be used to adapt the order
in which content is shown to you, so that it is even easier for you to find
(non-advertising) content that matches your interests.

View details
Consent (24 vendors)


MEASURE ADVERTISING PERFORMANCE

Information regarding which advertising is presented to you and how you interact
with it can be used to determine how well an advert has worked for you or other
users and whether the goals of the advertising were reached. For instance,
whether you saw an ad, whether you clicked on it, whether it led you to buy a
product or visit a website, etc. This is very helpful to understand the
relevance of advertising campaigns.

View details
Consent (77 vendors)Legitimate interest (46 vendors)


MEASURE CONTENT PERFORMANCE

Information regarding which content is presented to you and how you interact
with it can be used to determine whether the (non-advertising) content e.g.
reached its intended audience and matched your interests. For instance, whether
you read an article, watch a video, listen to a podcast or look at a product
description, how long you spent on this service and the web pages you visit etc.
This is very helpful to understand the relevance of (non-advertising) content
that is shown to you.

View details
Consent (32 vendors)Legitimate interest (14 vendors)


UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM DIFFERENT
SOURCES

Reports can be generated based on the combination of data sets (like user
profiles, statistics, market research, analytics data) regarding your
interactions and those of other users with advertising or (non-advertising)
content to identify common characteristics (for instance, to determine which
target audiences are more receptive to an ad campaign or to certain contents).

View details
Consent (57 vendors)Legitimate interest (22 vendors)


DEVELOP AND IMPROVE SERVICES

Information about your activity on this service, such as your interaction with
ads or content, can be very helpful to improve products and services and to
build new products and services based on user interactions, the type of
audience, etc. This specific purpose does not include the development or
improvement of user profiles and identifiers.

View details
Consent (67 vendors)Legitimate interest (37 vendors)


USE LIMITED DATA TO SELECT CONTENT

Content presented to you on this service can be based on limited data, such as
the website or app you are using, your non-precise location, your device type,
or which content you are (or have been) interacting with (for example, to limit
the number of times a video or an article is presented to you).

View details
Consent (12 vendors)Legitimate interest (3 vendors)


ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

View details


DELIVER AND PRESENT ADVERTISING AND CONTENT

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

View details


SAVE AND COMMUNICATE PRIVACY CHOICES

The choices you make regarding the purposes and entities listed in this notice
are saved and made available to those entities in the form of digital signals
(such as a string of characters). This is necessary in order to enable both this
service and those entities to respect such choices.

View details


MATCH AND COMBINE DATA FROM OTHER DATA SOURCES

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

View details


LINK DIFFERENT DEVICES

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

View details


IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

View details


USE PRECISE GEOLOCATION DATA

With your acceptance, your precise location (within a radius of less than 500
metres) may be used in support of the purposes explained in this notice.

View details
Consent

How this consent management platform (CMP) works:

CMP privacy choices


STORAGE, DURATION, AND USAGE DETAILS

The choices you make with this CMP regarding the purposes and entities will
affect how personalized advertising is presented to you. We need to store these
choices to respect them on future visits, and they are stored differently based
on the type of site or app you're using:
 * For sites, your choices are saved in a cookie named “FCCDCF” for a maximum
   duration of 390 days.
 * For apps, your choices are saved in device storage prefixed by “IABTCF_”.
   Your choices will be invalidated after 390 days and overwritten once you make
   new privacy choices on this app.
 * For accelerated mobile page (AMP) sites, your choices are saved in local
   storage prefixed by “amp-store”. Your choices will be invalidated after 390
   days and overwritten once you make new privacy choices on this site.

Vendor preferences

Accept all



Confirm choices

Vendor preferences





CONFIRM OUR VENDORS

Vendors can use your data to provide services. Declining a vendor can stop them
from using the data you shared.

TCF vendors


EXPONENTIAL INTERACTIVE, INC D/B/A VDX.TV

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device identifiers, Probabilistic
identifiers, Browsing and interaction data, Non-precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


ROQ.AD GMBH

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


ADMAXIM LIMITED

Cookie duration: 30 (days).

Data collected and processed: IP addresses, Probabilistic identifiers, Browsing
and interaction data

more

Cookie duration resets each session.


View details | Privacy policy
Consent


INDEX EXCHANGE INC.

Cookie duration: 395 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Non-precise location data, Precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


QUANTCAST

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


BEESWAXIO CORPORATION

Cookie duration: 395 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


SOVRN, INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


ADIKTEEV

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Non-precise location data, Users’ profiles

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


RTB HOUSE S.A.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


THE UK TRADE DESK LTD

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


NEXXEN INC.

Cookie duration: 180 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


EPSILON

Cookie duration: 184 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


YAHOO EMEA LIMITED

Cookie duration: 397 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


ADVENTORI SAS

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device identifiers, Probabilistic
identifiers, Browsing and interaction data, User-provided data, Non-precise
location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


TRIPLE LIFT, INC.

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


XANDR, INC.

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


NEORY GMBH

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


NEXXEN GROUP LLC

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Non-precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
ConsentLegitimate interest


NEURAL.ONE

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics,
Probabilistic identifiers, Browsing and interaction data, Non-precise location
data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


ADITION (VIRTUAL MINDS GMBH)

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


ACTIVE AGENT (VIRTUAL MINDS GMBH)

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


TABOOLA EUROPE LIMITED

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


EQUATIV

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


ADFORM A/S

Cookie duration: 3650 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


MAGNITE, INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


RATEGAIN ADARA INC

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more




View details | Storage details | Privacy policy
Consent


SIFT MEDIA, INC

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Non-precise location data, Precise location data

more




View details | Privacy policy
Consent


RAKUTEN MARKETING LLC

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


LUMEN RESEARCH LIMITED

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Browsing and
interaction data, Non-precise location data

more




View details | Privacy policy
Legitimate interest


AMAZON AD SERVER

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


OPENX

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


YIELDLAB (VIRTUAL MINDS GMBH)

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


ROKU ADVERTISING SERVICES

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


NANO INTERACTIVE GROUP LTD.

Doesn't use cookies.

Data collected and processed: Device characteristics, Browsing and interaction
data, Non-precise location data

more




View details | Privacy policy
Consent


SIMPLIFI HOLDINGS LLC

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device identifiers, Precise location
data

more

Uses other forms of storage.


View details | Privacy policy
Consent


PUBMATIC, INC

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


COMSCORE B.V.

Cookie duration: 720 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


FLASHTALKING

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Users’ profiles,
Privacy choices

more




View details | Privacy policy
Consent


PULSEPOINT, INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


SMAATO, INC.

Cookie duration: 21 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


SEMASIO GMBH

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device identifiers, Browsing and
interaction data, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


CRIMTAN HOLDINGS LIMITED

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
ConsentLegitimate interest


GENIUS SPORTS UK LIMITED

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Users’ profiles,
Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


CRITEO SA

Cookie duration: 390 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Users’ profiles,
Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


ADLOOX SA

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


BLIS GLOBAL LIMITED

Cookie duration: 400 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


LOTAME SOLUTIONS, INC

Cookie duration: 274 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


LIVERAMP

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


GROUPM UK LIMITED

Cookie duration: 395 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
ConsentLegitimate interest


LOOPME LIMITED

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


DYNATA LLC

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


ASK LOCALA

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Non-precise location data, Precise location data, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


AZIRA

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Precise
location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


DOUBLEVERIFY INC.

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics,
Probabilistic identifiers, Browsing and interaction data, Non-precise location
data, Privacy choices

more




View details | Privacy policy
Legitimate interest


BIDSWITCH GMBH

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


IPONWEB GMBH

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


NEXTROLL, INC.

Cookie duration: 183 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, User-provided data, Non-precise
location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


TEADS FRANCE SAS

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Users’
profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


STRÖER SSP GMBH (SSP)

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


OS DATA SOLUTIONS GMBH

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


PERMODO GMBH

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Users’
profiles, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


PLATFORM161 B.V.

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


BASIS GLOBAL TECHNOLOGIES, INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session.


View details | Privacy policy
ConsentLegitimate interest


SMADEX, S.L.U.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, User-provided data, Non-precise location
data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


BOMBORA INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


EASYMEDIA GMBH

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Users’ profiles, Privacy
choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


REMERGE GMBH

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


ADVANCED STORE GMBH

Cookie duration: 365 (days).

Data collected and processed: Device identifiers

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


MAGNITE CTV, INC.

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


DELTA PROJECTS AB

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more




View details | Storage details | Privacy policy
ConsentLegitimate interest


USEMAX ADVERTISEMENT (EMEGO GMBH)

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Users’ profiles

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


EMETRIQ GMBH

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


PUBLICIS MEDIA GMBH

Cookie duration: 1825 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


M.D. PRIMIS TECHNOLOGIES LTD.

Cookie duration: 25 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Privacy choices

more




View details | Storage details | Privacy policy
ConsentLegitimate interest


ONETAG LIMITED

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


CLOUD TECHNOLOGIES S.A.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


SMARTOLOGY LIMITED

Doesn't use cookies.

Data collected and processed: IP addresses

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


IMPROVE DIGITAL

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
ConsentLegitimate interest


ADOBE ADVERTISING CLOUD

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device identifiers,
Authentication-derived identifiers, Privacy choices

more




View details | Storage details | Privacy policy
ConsentLegitimate interest


BANNERFLOW AB

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device characteristics, Non-precise
location data, Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


TABMO SAS

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


INTEGRAL AD SCIENCE (INCORPORATING ADMANTX)

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Browsing and
interaction data, Non-precise location data, Privacy choices

more




View details | Privacy policy
Legitimate interest


WIZALY

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics,
Authentication-derived identifiers, Browsing and interaction data, Non-precise
location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


WEBORAMA

Cookie duration: 393 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


JIVOX CORPORATION

Cookie duration: 30 (days).

Data collected and processed: IP addresses, Device identifiers, Browsing and
interaction data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


VISTAR MEDIA EMEA BV

Doesn't use cookies.

Data collected and processed: Non-precise location data

more




View details | Privacy policy
Consent


ON DEVICE RESEARCH LIMITED

Cookie duration: 30 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, User-provided data, Non-precise
location data, Precise location data

more




View details | Storage details | Privacy policy
Consent


ROCKABOX MEDIA LTD

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Browsing and
interaction data, Non-precise location data

more




View details | Storage details | Privacy policy
Legitimate interest


EXACTAG GMBH

Cookie duration: 180 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Privacy choices

more

Cookie duration resets each session.


View details | Privacy policy
Consent


CELTRA INC.

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Precise location data

more

Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


MAINADV SRL

Cookie duration: 30 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, User-provided data, Non-precise
location data, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


GEMIUS SA

Cookie duration: 1825 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


THE KANTAR GROUP LIMITED

Cookie duration: 914 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


NIELSEN MEDIA RESEARCH LTD.

Cookie duration: 120 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


SOLOCAL SA

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, User-provided data, Non-precise
location data, Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


PIXALATE, INC.

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data

more




View details | Storage details | Privacy policy
Consent


NUMBERLY

Cookie duration: 180 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


AUDIENCEPROJECT A/S

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


DEMANDBASE, INC.

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


EFFILIATION / EFFINITY

Cookie duration: 30 (days).

Data collected and processed: Device characteristics

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


ARRIVALIST CO.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Non-precise location data

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


SEENTHIS AB

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics

more




View details | Privacy policy


COMMANDERS ACT

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device identifiers

more




View details | Storage details | Privacy policy
Consent


TRAVEL AUDIENCE GMBH

Cookie duration: 397 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data,
Users’ profiles

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


HUMAN

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Non-precise location data

more




View details | Privacy policy
Legitimate interest


BLENDEE SRL

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


INNOVID LLC

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Non-precise location data, Privacy
choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
ConsentLegitimate interest


PAPIRFLY AS

Doesn't use cookies.

Data collected and processed: Device characteristics

more




View details | Privacy policy
Legitimate interest


NEUSTAR, INC., A TRANSUNION COMPANY

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


VERVE GROUP EUROPE GMBH

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


OTTO (GMBH & CO KG)

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device identifiers, Browsing and
interaction data, User-provided data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


ADOBE AUDIENCE MANAGER, ADOBE EXPERIENCE PLATFORM

Cookie duration: 180 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


LOCALSENSOR B.V.

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Non-precise location data, Precise location data, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


ONLINE SOLUTION

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Precise location data, Users’
profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
Consent


RELAY42 NETHERLANDS B.V.

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
User-provided data, Users’ profiles, Privacy choices

more




View details | Storage details | Privacy policy
Consent


GP ONE GMBH

Cookie duration: Uses session cookies.

Data collected and processed: IP addresses, Device characteristics, Browsing and
interaction data, User-provided data, Non-precise location data, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


LIFTOFF MONETIZE AND VUNGLE EXCHANGE

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, User-provided data, Non-precise location data,
Precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


THE MEDIAGRID INC.

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Precise location data, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


REPPUBLIKA RESEARCH & ANALYTICS AUSTRIA GMBH

Cookie duration: 180 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data, Users’
profiles

more

Uses other forms of storage.


View details | Privacy policy
Consent


CINT AB

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Privacy choices

more

Uses other forms of storage.


View details | Privacy policy
Consent


GOOGLE ADVERTISING PRODUCTS

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
ConsentLegitimate interest


GFK GMBH

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
User-provided data, Non-precise location data, Users’ profiles, Privacy choices

more

Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


REVJET

Cookie duration: 365 (days).

Data collected and processed: IP addresses, Device identifiers, Non-precise
location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


PROTECTED MEDIA LTD

Doesn't use cookies.

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data

more




View details | Privacy policy
Legitimate interest


CLINCH LABS LTD

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
ConsentLegitimate interest


ORACLE DATA CLOUD - MOAT

Doesn't use cookies.

Data collected and processed: IP addresses, Non-precise location data

more




View details | Privacy policy
Legitimate interest


HEARTS AND SCIENCE MÜNCHEN GMBH

Cookie duration: 60 (days).

Data collected and processed: IP addresses

more

Cookie duration resets each session.


View details | Privacy policy
Consent


AMAZON ADVERTISING

Cookie duration: 396 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Users’ profiles, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policy
Consent


MOLOCO, INC.

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Non-precise location data

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policy
ConsentLegitimate interest


ADTRIBA GMBH

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Authentication-derived identifiers, Browsing and interaction data,
Non-precise location data, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent


ENSIGHTEN

Cookie duration: 1825 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Legitimate interest


EBAY INC

Cookie duration: 90 (days).

Data collected and processed: IP addresses, Device characteristics, Privacy
choices

more




View details | Storage details | Privacy policy
Consent


METRIXLAB NEDERLAND B.V.

Cookie duration: 730 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Browsing and interaction data, User-provided data

more

Uses other forms of storage.


View details | Privacy policy
Consent


HURRA COMMUNICATIONS GMBH

Cookie duration: 366 (days).

Data collected and processed: IP addresses, Device characteristics, Device
identifiers, Probabilistic identifiers, Authentication-derived identifiers,
Browsing and interaction data, Non-precise location data, Precise location data

more

Cookie duration resets each session.


View details | Storage details | Privacy policy
Consent

Ad partners


AKAMAI

Privacy policy
Consent


META

Privacy policy
Consent


AUNICA

Privacy policy
Consent


BOOKING.COM

Privacy policy
Consent


C3 METRICS

Privacy policy
Consent


IBM

Privacy policy
Consent


EVIDON

Privacy policy
Consent


ADACADO

Privacy policy
Consent


INTELLIAD

Privacy policy
Consent


DSTILLERY

Privacy policy
Consent


MEDIAMATH

Privacy policy
Consent


ZMS

Privacy policy
Consent


OMNICOM MEDIA GROUP

Privacy policy
Consent


RESONATE

Privacy policy
Consent


SMART

Privacy policy
Consent


SOJERN

Privacy policy
Consent


TRADEDOUBLER AB

Privacy policy
Consent


TRUSTARC

Privacy policy
Consent


TRUEFFECT

Privacy policy
Consent


TRAVEL DATA COLLECTIVE

Privacy policy
Consent


ADVOLUTION.CONTROL

Privacy policy
Consent


LIFESTREET

Privacy policy
Consent


BATCH MEDIA

Privacy policy
Consent


VODAFONE GMBH

Privacy policy
Consent


MAGNITE

Privacy policy
Consent


SCENESTEALER

Privacy policy
Consent


NETQUEST

Privacy policy
Consent


MANAGE.COM

Privacy policy
Consent


CLOUDFLARE

Privacy policy
Consent


SALESFORCE DMP

Privacy policy
Consent


NETFLIX

Privacy policy
Consent


EBUILDERS

Privacy policy
Consent


APPLOVIN CORP.

Privacy policy
Consent


FRACTIONAL MEDIA

Privacy policy
Consent


RACKSPACE

Privacy policy
Consent


MSI-ACI

Privacy policy
Consent


ADMETRICS

Privacy policy
Consent


NAVEGG

Privacy policy
Consent


ADMEDO

Privacy policy
Consent


KOCHAVA

Privacy policy
Consent


MOBITRANS

Privacy policy
Consent


ADEX

Privacy policy
Consent


IMPACT

Privacy policy
Consent


SPOTAD

Privacy policy
Consent


AARKI

Privacy policy
Consent


SFR

Privacy policy
Consent


CABLATO

Privacy policy
Consent


WAYSTACK

Privacy policy
Consent


TRESENSA

Privacy policy
Consent


ADLUDIO

Privacy policy
Consent


GSKINNER

Privacy policy
Consent


CUBED

Privacy policy
Consent


OPTOMATON

Privacy policy
Consent


DENTSU AEGIS NETWORK

Privacy policy
Consent


DIGISEG

Privacy policy
Consent


HAENSEL AMS

Privacy policy
Consent


BDSK HANDELS GMBH & CO. KG

Privacy policy
Consent


OBJECTIVE PARTNERS

Privacy policy
Consent


MARKETING SCIENCE CONSULTING GROUP, INC.

Privacy policy
Consent


DENTSU

Privacy policy
Consent


KOBLER

Privacy policy
Consent


WIDESPACE

Privacy policy
Consent


VIMEO

Privacy policy
Consent


ORACLE DATA CLOUD

Privacy policy
Consent

Accept all



Confirm choices

Close